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Many details of the conformational dynamics underlying transitions during pre-
mRNA splicing, particularly during the catalytic phase, remain unclear despite our 
deep knowledge of spliceosome composition.  The complex assembly phase that 
precedes catalysis, and the involvement of several motifs in multiple interactions 
along the splicing pathway, exacerbate the difficulty of accessing splicing 
catalysis experimentally. 
 
snRNAs likely form some or all of the spliceosomal active site.  We attempted to 
establish an snRNA-only splicing system as a means to bypass assembly and 
recapitulate splicing catalysis.  Our approach, however, yielded a 2’-3’ bond-
forming ribozyme activity in a linker region in our fused snRNA construct; this 
highlights the uncertainty inherent in minimised systems and, by contrast, the 
strength of experimental approaches based on complete spliceosomes. 
 
We describe the in vivo analysis of the interaction between the intron branch site 
(BS) and its cognate region of U2 snRNA; the absolute requirement for this base-
pairing interaction during spliceosome assembly has previously impeded the 
investigation of its role and fate during splicing catalysis.  By substituting the 
entire duplex, we produced nonessential second-copy spliceosomes in which 
assembly and catalysis each partially limit the splicing reaction.  Using such 
spliceosomes, we established unconfirmed details of branch site-U2 interaction, 
including a requirement for this duplex in bulging the branch nucleophile for first 
step splicing catalysis, and similar spatial organisation of key components of the 
spliceosome and group II self-splicing introns.  Our second-copy spliceosomes 
should represent a system that can be extended to include other spliceosomal 
components, allowing the in vivo investigation of normally lethal, and even 
dominant lethal, alleles. 
  
In another line of experiments, we used RT-PCR to identify the products of 
reactions in which multiple sites in the BS-binding region of U2 were used in 
trans as 5’ splice sites during the splicing of a reporter gene.  Characterisation of 
trans-splicing products revealed previously unknown dynamics in BS-U2 pairing, 
suggesting that this interaction may be disrupted between early assembly and 
first step catalysis, and again before the second step of the reaction.  Our results 
also indicate a surprising degree of flexibility in the active site of the normally 
stringent S. cerevisiae spliceosome. 
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CHAPTER 1. INTRODUCTION. 
 
A number of reviews have been published over the past decade (1-11), 
addressing numerous aspects of pre-mRNA splicing and its coordination with 
other nuclear events.  This introduction will focus on selected themes, 
highlighting the dynamic nature of both the assembly and catalytic phases.  
Multiple transitions in spliceosome assembly and catalysis can be modulated by 
alterations in the identity or activity of spliceosomal components, or by 
modulation of the stability of interactions between the pre-mRNA substrate and 
the spliceosome.  For a given intron and set of cellular conditions, one or more of 
these transitions will limit splicing and thus be available as a potential point of 
regulation.  Changes in the efficiency of any transition in the entire splicing 
pathway can therefore result in regulated – and thus alternative – splicing. 
THE DYNAMICS OF SPLICEOSOME ASSEMBLY 
The classical, sequential view of spliceosome assembly (2), shown schematically 
in Fig. 1-1,  holds that the 5’ splice site (5’SS) is first bound by U1 snRNP, then 
the branch site (BS) and 3’SS by U2 snRNP and associated protein factors to 
form a pre-spliceosome, also known as complex A.  The [U4/U6.U5] tri-snRNP 
joins the complex to form complex B, and a series of conformational and 
compositional changes result, including the loss of U1 and U4 snRNPs to leave 
U2/5/6.  Recruitment of the CDC5L complex (known as the NTC in S. cerevisiae 
– this nomenclature will be used throughout) follows (12), giving rise to an 
2 
activated spliceosome.  Assembly can be stimulated or repressed by the binding 
of general or specific splicing factors to snRNPs and pre-mRNA; snRNPs can 
also interact both with pre-mRNA and with each other.  Spliceosome assembly is 
thus highly cooperative, and the fact that many interactions can occur 
independently of one another in fact results in an assembly cascade that does 




Figure 1-1. The classical, sequential view of spliceosome assembly. 
 
An extreme example of cooperative assembly is the penta-snRNP, which 
contains all five snRNPs in the absence of pre-mRNA and can be isolated from 
3 
S. cerevisiae.  Although the penta-snRNP alone is not competent to catalyse 
splicing, addition of nuclease-treated cell extract restores its activity without 
requiring disassembly and reassembly (13).  Together with the observation of 
splicing in the absence of U1 recruitment in multiple systems (2), this finding 
suggests that there is unlikely to be any essential compositionally defined 
assembly intermediate prior to the activated spliceosome.  Rather, a number of 
potential assembly pathways can lead to this same point.  For a given substrate, 
the stabilities of intermediates along a given pathway might be such that this 
mode of assembly is observed to the exclusion of all others.  In such cases, 
stable intermediates may be isolated (14), but this does not mean that the 
assembly pathway in question is an obligate one for any substrate. 
 
Spliceosome assembly appears to be driven by the stochastic association of 
snRNPs with pre-mRNA.  Data from photobleaching experiments using various 
GFP-tagged spliceosomal components are consistent with free diffusion of 
snRNPs within the nucleus and their transient, random association with pre-
mRNA (15).  Two major roles of factors stimulating or repressing assembly in 
such a system would be to increase or decrease the local concentration of 
snRNPs on or near a transcript, and to modulate the stability of snRNP-pre-
mRNA and inter-snRNP interactions.  Given that the CTD of RNA polymerase II 
is one of the multiple regulators that can interact with snRNPs to modulate 
assembly (3), future studies must address how assembly is modulated in 
response to transcriptional events and chromatin structure.  In addition, it is 
4 
possible that future work will identify more entry points into the spliceosome 
assembly pathway – for example, “re-initiation” by postcatalytic U2/5/6 
complexes. 
 
Another convergence point during spliceosome assembly exists due to the two 
possible orientations of interaction between the U1 and U2 snRNPs.  U1-U2 
interaction can occur across the intron to be removed by the spliceosome that 
will ultimately contain these two snRNPs (intron definition); in multi-intron genes, 
however, this interaction can also occur across an exon such that U1 bound at 
the 5’SS of the downstream intron interacts with U2 bound to the BS-3’SS of the 
upstream intron (exon definition).  A reporter gene with long exons is spliced 
efficiently only if the flanking introns are short (16), and increasing intron length in 
a model substrate favours exon definition (17), consistent with the interpretation 
that simple binding kinetics determine the predominant assembly pathway for a 
given pre-mRNA substrate.  It is not known whether multiple U1 snRNPs can 
interact with a single U2, or vice versa.  If such polymeric interactions are not 
possible, inter-snRNP interactions promoting exon definition at a given splice site 
will preclude intron definition.  An exon-defined assembly intermediate must 
therefore make the transition to an intron-defined state in order for functional 
splicing to proceed. Indeed, splicing can be inhibited by preventing the 
establishment of intron definition, for example by hnRNP L binding to an exonic 
splicing silencer and stabilising exon definition interactions between U1 and U2 
(18).  hnRNP L has a stimulatory effect when bound within an intron, likely due to 
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facilitation of a cross-intron U1-U2 interaction (19).  Similarly, the binding of SR 
proteins within an intron can inhibit splicing (20), whereas SR binding within 
exons is generally stimulatory (4).  These observations are consistent with the 
existence of mutually exclusive interactions during exon- and intron-defined 
states. 
 
Circular exons, the predicted products of splicing from an exon-defined state, 
have been detected in several systems (21-23).  The formation of such products, 
even at a slow rate, suggests that the maintenance of U1-U2 interaction across 
an exon (i.e. with the wrong polarity) is not sufficient to prevent the formation of a 
catalytically competent spliceosome.  It is therefore likely that a polarity sensing 
mechanism normally exists to distinguish between exon- and intron-defined 
complexes. U1-U2 interactions, when intron-defined, may provide a binding 
surface for the [U4/U6.U5] tri-snRNP, with exon-defined complexes normally 
lacking such a surface.  The recruitment of non-tri-snRNP proteins is also likely 
to play a role in this transition, with candidates for proteins involved in polarity 
sensing expected to bind only to intron-defined complexes.  Although no 
mechanism or factors responsible for such polarity sensing are known, DEK, a 
chromatin-associated protein not required for early assembly but important for 
3’SS definition and splicing catalysis (24), could represent one such factor.  
Proteomic analysis of human spliceosome assembly intermediates suggests that 
DEK joins the complex during or after the exon definition-intron definition 
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transition (25).  In addition, there is no DEK homologue in S. cerevisiae, whose 
almost exclusively single-intron genes presumably lack an exon-defined stage. 
THE ROLE OF RNA STRUCTURE 
Consistent with many alternative splicing factors having a role in increasing or 
decreasing the local concentration of snRNPs on transcripts, a large number of 
sequence-specific RNA binding proteins have been shown to modulate 
spliceosome assembly (26).  Several protein motifs that bind single stranded 
RNA have been characterised, and these are commonly found in splicing factors.  
Consistent with their action in a single-stranded state, a set of splicing enhancers 
and silencers has been confirmed bioinformatically to be more single stranded 
than bulk sequence, and to function more effectively when placed in the loop 
than the stem of a hairpin structure (27).  The stabilisation or destabilisation of 
secondary structure around such regulatory elements could therefore serve as a 
potential mechanism to reduce or enhance, respectively, their effects on splicing. 
 
All evidence suggests that splice sites themselves must be single stranded in 
order to allow spliceosome assembly, with secondary structure inhibiting U1 and 
U2 snRNP binding.  Inclusion of the 3’SS in a hairpin is inhibitory for splicing, 
although this can be overcome by the presence of a single stranded ‘helper’ 
downstream 3’SS, likely recognised during assembly (28).  A particularly elegant 
example of alternative splicing regulation by direct modulation of secondary 
structure around splice sites is the control of alternative splicing by a thiamine 
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pyrophosphate (TPP) riboswitch in Neurospora crassa (29).  When TPP 
concentration is low, the pre-mRNA adopts a structure such that an otherwise 
favoured downstream 5’SS is occluded, and the branch region is flexible.  
Splicing proceeds using a suboptimal upstream 5’SS to produce mRNA encoding 
a functional NMT1 protein.  When TPP concentration is high, however, 
conformational changes in the riboswitch cause structure around the favoured 
downstream 5’SS to be disrupted, leading to the predominant production of a 
longer mRNA containing uORFs that prevent NMT1 translation; in addition, the 
branch region is partially occluded, yielding an overall decrease in splicing 
efficiency.  It is likely that similar examples of splicing regulation, mediated by 
proteins or small molecules, will be discovered in other systems: how common 
such mechanisms of splicing regulation will prove to be remains an open 
question. 
 
Secondary structure is not always inhibitory to splicing; for example, the S. 
cerevisiae RP51B intron contains complementary sequences close to the 5’SS 
and BS that bring the ends of the intron together and aid spliceosome assembly 
(30), and it is possible that this is a common way to increase the efficiency of U1-
U2 binding and intron definition.  The splicing of exon clusters 4 and 6 in the well-
characterised Dscam gene in Drosophila provides two further examples of 
stimulatory secondary structures.  Disruption of the iStem – a large hairpin loop 
downstream of exon 3 – interferes with the splicing of all twelve exon 4 variants 
(31), although the mechanism by which this stem stimulates exon 4 splicing 
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remains unclear.  The basis of maintenance of mutually exclusive splicing in the 
exon 6 cluster, however, is better understood.  Each exon 6 variant is preceded 
by a selector sequence complementary to a docking site downstream of exon 5.  
Interaction between a given selector sequence and the docking site leads to 
splicing of the following exon and, as the docking site is thus removed from the 
transcript, the inclusion of further exon 6 variants is suppressed under normal 
conditions (32).  Knockdown of the hnRNP protein hrp36 leads to the inclusion of 
multiple exon 6 variants, suggesting that this protein mediates the repression of 
splicing across the cluster (33). 
 
hnRNP proteins normally act as general inhibitors of splicing: they are 
antagonised by the generally activating SR proteins (4).  There is increasing 
evidence that SR proteins exert at least some of their stimulatory effect via the 
stabilisation of RNA-RNA interactions during both spliceosome assembly and 
splicing catalysis.  A pre-mRNA with a 5’ exon as short as one nucleotide can 
undergo SR protein-dependent splicing in HeLa extract, suggesting a post-
assembly role for these proteins (34).  The arginine-serine rich (RS) domain of a 
natural SR protein, or an artificial domain comprising multiple RS repeats, when 
tethered to pre-mRNA, directly contacts the branch site and facilitates 
prespliceosome formation (35); it is thought that the BS is already base paired to 
U2 snRNA in such assembly intermediates (36).  Defects due to SR protein 
depletion can be suppressed by increasing the strength of the interaction 
between the 5’SS and U6 snRNA that is required for the first catalytic step (37, 
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38).  Subsequent work has demonstrated that an RS domain can be crosslinked 
to the intronic 5’SS region bound to U6 snRNA during the first step of splicing, 
and subsequently to the exonic 5’SS region bound to U5 snRNA during the 
second step (39).  This argues for the involvement of enhancer-recruited SR 
proteins not only in assembly but also during the catalytic phase of splicing. 
 
Data concerning the role of SR proteins in alternative splicing have generally 
been interpreted with assembly in mind: such data might now need to be 
reconsidered, as the stabilisation of duplexes could produce diverse phenotypes 
during the dynamic and structurally complex catalytic phase.  It is also possible 
that hnRNP proteins might exert some of their effect via the disruption of RNA-
RNA interactions – most simply by sequence sequestration.  The mechanistic 
basis for duplex stabilisation by SR proteins remains unclear, as does the issue 
of whether this stabilisation is general or protein-duplex specific, with defined SR 





Figure 1-2. The two steps of splicing catalysis. 
THE TRANSITION BETWEEN THE TWO CHEMICAL STEPS 
Splicing catalysis consists of two successive transesterification reactions: in the 
first step, the 2’ hydroxyl of the BS nucleotide nucleophilically attacks the 5’SS to 
yield a lariat intermediate and a free 5’ exon; in the second step, this free exon 
nucleophilically attacks the 3’SS, producing mRNA and an excised lariat intron 
(Fig. 1-2).  The 3’SS remains sensitive to nuclease degradation until after the first 
step; this suggests that it enters the active site after first step catalysis (40) – a 
repositioning event that would require removal of the newly formed branch 
structure of the lariat intermediate from the catalytic centre.  Indeed, multiple 
lines of evidence suggest that the 3’SS replaces the branch structure, with the 5’ 
exon remaining in a fixed position relative to loop 1 of U5 snRNA.  Crosslinks 
between U5 loop 1 and the terminal nucleotide of the 5’ exon can be chased 
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through both steps of splicing: those between loop 1 and position +2 of the intron, 
however, can be chased into a lariat intermediate but not a lariat product (41), 
suggesting disruption of U5-intron 5’SS interaction following the first step and 
consistent with genetic and biochemical interactions between loop 1 and the 
3’SS during the second step (42) and references therein).  Further crosslinking 
studies show juxtaposition of the 5’SS and U6 snRNA positions U47-A51 during 
the first step (proposed RNA-RNA interactions in the first step catalytic centre are 
shown in Fig. 1-3), and positions G39-A44 when in the lariat intermediate branch 
structure (43).  Genetic evidence also supports the disruption of the 5’SS-U6 
pairing required for the first step of splicing: the 5’SS A3C mutation (/GUAUGU to 
/GUCUGU) hyperstabilises pairing between the 5’SS and U6; this mutation 
inhibits the second step, but can be suppressed by mutations that destabilise 







Figure 1-3. Schematic of RNA:RNA interactions during the first step of 
splicing.   
Pre-mRNA is shown in black, U2 snRNA in red, U5 snRNA in grey, and U6 
snRNA in green; numbering corresponds to S. cerevisiae snRNAs and indicates 
U6 nucleotides discussed in this review.  Nucleophilic attack of the 5'SS by BS 
(the first catalytic step of the splicing reaction) is shown. 
 
The splicing defect due to a hyperstabilised 5’SS-U6 helix can be suppressed not 
only directly by duplex destabilisation, but also by the U6 U57A mutation, a 
variety of mutations in Prp8 (44) or deletion of the NTC component Isy1 (45).  
Mutations that suppress the second step defect of an A3C intron also increase 
the efficiency of the second step for a variety of other intron mutations, including 
those at the branch site adenosine and 3’SS; commensurate with their 
stimulation of the second step, these suppressors inhibit the first step of splicing.  
There also exists the opposite class of spliceosomal mutants: those that increase 
13 
the efficiency of the first step at the expense of the second (46).  The existence 
of two opposing classes of suppressor allele, each capable of suppressing a 
wide range of intron mutations, suggests that suppression is not necessarily via 
direct contact between mutated bases/amino acids, but that the spliceosomal 
conformations competent to carry out the first and second steps are in 
competition with one another.  Mutations that stabilise the first step conformation 
relative to the second will stimulate the first step and inhibit the second, while the 
opposite will be true for those that cause relative stabilisation of the second step 
conformation.  As a mutation is more likely to disrupt an interaction than to form a 
new one, it is likely that relative stabilisation takes the form of destabilisation of 
the competing conformation, such that most first step suppressors would 
destabilise the second step conformation and vice versa.  At present, however, 
the molecular basis of the action of these general suppressor mutations is 
unknown.  This two-state model provides a mechanism by which modulation of 
the stabilities of conformational states of the catalytic spliceosome can modulate 
the efficiency of splicing of suboptimal substrates.  Such tolerance of suboptimal 
splice sites is manifested in metazoa as alternative splicing, meaning that local or 
global modulation of conformational stability during catalysis could impact the 
splicing pattern of individual transcripts, or of classes thereof, respectively. 
14 
 
Figure 1-4. Two-state conformational model of the catalytic spliceosome.   
Spliceosomal conformations competent to carry out the first and second steps 
are in competition with one another.  In addition, two opposing classes of prp8 
alleles modulate an event in the first-to-second step transition distinct from that 
modulated by alleles of prp16 and U6 snRNA (upper) (47); thus, two distinct 
events (‘opening’ and ‘substrate repositioning’) can be distinguished.  
Accompanying conformational changes in U2 snRNA stem II (lower) parallel 
these two events (48, 49). 
 
Recent detailed analysis of the interplay between global suppressor mutations 
has led to a refinement of the two-state model (Fig. 1-4).  First and second step 
suppressor point mutations combined in the same molecule of Prp8, a large and 
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exceptionally well-conserved U5 snRNP protein that makes contacts with the 
5’SS, BS and 3’SS (50), cancel one another’s effects and produce a phenotype 
resembling wild-type Prp8.  A different effect is observed, however, when Prp8 
second step suppressor mutations are combined with first step suppressors in 
U6 snRNA or Prp16, the ATPase that modulates the first-to-second step 
transition (51); in this instance, the suppressors act in concert such that both the 
first and second steps are improved.  Cancellation by the opposing classes of 
prp8 allele indicates that these prp8 alleles act at the same kinetic step as one 
another, whereas the additive nature of the Prp16/U6-Prp8 suppressor pairs 
requires that they be affecting different kinetic steps in the transition.  These 
observations have led to a model in which the transition between the two steps 
has multiple phases, requiring an ‘opening’ step (affected by prp16 and U6 
mutants) and a repositioning step (affected by prp8 mutants), followed by 
‘closure’ into the second step conformation (47). 
 
The suggestion that transitions traditionally considered as one step actually 
comprise multiple phases has important implications for future proteomic, 
biochemical and structural studies of the spliceosome.  A complex containing a 
lariat intermediate and a free 5’ exon could plausibly be in one of at least four 
conformations that are currently compositionally and conformationally undefined: 
post-first step but pre-opening, open but un-repositioned, open and repositioned, 
or closed pre-second step.  In the first or fourth case the purified complex would 
be competent to carry out first or second step catalysis, respectively, whereas 
16 
the open complexes are presumably not catalytically competent.  Accurately 
ascertaining the state of purified complexes is therefore essential in order to 
allow coherent and reliable insights into the mechanism of splicing.  As will be 
discussed below, there is an emerging view that multiple transitions along the 
splicing pathway resemble one another, so it is possible that the transition 
between the catalytic steps is not the only one composed of several smaller 
remodelling events. 
CONFORMATIONAL TOGGLING, ASYMMETRY, AND THE RE-USE OF 
MOTIFS 
Alleles of prp22, the ATPase involved in transitions during and after the second 
step of splicing, produce a cold-sensitive phenotype due to an mRNA release 
defect; a screen for suppressors of this phenotype identified a prp8 allele (52) 
subsequently shown also to act as a general suppressor of first step splicing 
defects (47).  Indeed, all known first step suppressor alleles of prp8 also 
suppress prp22 defects.  This observation is consistent with the hypothesis that 
these alleles destabilise the second step conformation of the spliceosome, 
thereby stimulating the surrounding steps on the splicing pathway (first step 
catalysis and mRNA release), but could also suggest some degree of similarity 
between these flanking states.  Consistent with the existence of such similarity, a 
growing number of interactions appear to be disrupted and re-form at defined 
stages of the splicing reaction – i.e. to toggle. 
 
17 
Many RNA-RNA interactions between snRNAs, as well as between snRNAs and 
pre-mRNA, have been identified, and take the form of (generally short) intra- and 
intermolecular helices (5).  Some of these interactions are mutually exclusive 
with others, which suggests that they might exist only transiently, or may toggle 
between competing conformations.  As previously noted, during the first catalytic 
step the UGU trinucleotide at positions 4-7 of the 5’SS base pairs with a 
conserved ACA in U6 snRNA (positions 47-49) (37).  During the second step, 
when the 5’SS is in the branch of the lariat intermediate, it is in proximity to U6 
positions 42-44 (43): interestingly, this region of U6 has also been shown to bind 
the 5’SS in early complexes (53, 54).  Thus, the same binding site may be used 
for the 5’SS before and after its involvement in first step catalysis.  Indeed, 
spliceosomal states even further apart on the splicing pathway display surprising 
similarities: the ATPase Brr2 disrupts the interaction between U4 and U6 
snRNAs during spliceosome assembly, allowing U6 to interact with U2 and the 
5’SS (55).  It has recently been demonstrated that Brr2 is activated by the GTP-
bound form of the U5 snRNP protein Snu114 and repressed by its GDP-bound 
form, and that Brr2 activation is required for spliceosome disassembly as well as 
U4/U6 unwinding (56).  GTP hydrolysis by Snu114 is not required for Brr2 
activation, suggesting a mechanism of action resembling that of classical G 
proteins.  Although the GAP and GEF acting on Snu114 have not been identified, 
it is tempting to speculate that the relevant conformational states of the 
spliceosome might perform these roles, akin to the action of the signal 
recognition particle itself as the GEF for SR-β (57). 
18 
 
Genetic work in S. cerevisiae provides another example of conformational 
toggling (48, 49).  The dynamic stem II region of U2 snRNA can form two 
mutually exclusive interactions, known as stem IIa and stem IIc.  Stabilisation of 
stem IIa stimulates prespliceosome formation but inhibits the first catalytic step, 
which can be promoted by stem IIc stabilisation or IIa destabilisation.  Disruption 
of stem IIc suppresses the splicing defect due to prp16 mutation, whereas 
disruption of IIa (and therefore relative IIc stabilisation) suppresses second step 
splicing defects.  These data are consistent with a model whereby stems IIa and 
IIc toggle, coexisting with the previously discussed open and closed forms of the 
spliceosome, respectively, with stem IIc therefore present during catalysis and IIa 
during repositioning (Fig. 1-4). 
 
It has recently been demonstrated that the spliceosome, like group II introns (58), 
can be induced to catalyse both the forward and the reverse reactions of splicing.  
Purified postcatalytic spliceosome/product complexes prepared using a release-
defective prp22 mutant, when incubated under mild buffer conditions, undergo 
remarkably efficient reversal of both catalytic steps (59).  Consistent with 
disparate states on the splicing pathway sharing conformational similarities as 
discussed above, F2, the forward reaction of the second step, and R1, the 
reverse of the first, are both favoured by the presence of KCl, while R2 is 
favoured by its absence.  Thus, KCl appears to stabilise both pre-first and post-
second step conformations of the spliceosome relative to the post-first, pre-
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second step conformation (it is possible that states in which the 5’SS is bound to 
its upstream U6 snRNA binding site are stabilised).  This observation provides 
further evidence for the global conformational similarity of the states before the 
first and after the second catalytic step of splicing.   We anticipate that further 
analysis will highlight the similarities and differences between other spliceosomal 
states, and clarify the extent to which conformational toggling is a general 
phenomenon in splicing. 
 
Although more examples of conformational toggling will likely be identified, many 
spliceosomal interactions are unlikely to reoccur once disrupted – for example 
5’SS binding by U1, which is replaced by a 5’SS-U6 interaction via the action of 
Prp28 (60).  In fact, a general theme in intermolecular interactions involving U6 
snRNA is that of asymmetry.  U6 mutations that disrupt a structure often have a 
more severe phenotype than corresponding mutations in the interacting partner, 
and incomplete suppression by compensatory changes is common.  For 
example, mutations on the U6 side of U2/U6 helix Ia are substantially more 
severe than those on the U2 side (61); this may suggest that helix Ia does not 
remain intact throughout the entire splicing reaction, and that the interactions of 
the U6 component when not engaged in this helix are more critical for splicing 
than those of the U2 component.  An alternative possibility is that involvement of 
helix Ia in a triple-helical interaction could give rise to the observed asymmetric 
phenotypes.  Similar asymmetry is observed for the conserved AGC triad of U6, 
which can interact with sequences in U4 snRNA, with U2 snRNA (to form helix 
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Ib), and within U6 to extend the intramolecular stem loop (ISL) (5).  Most 
mutations in AGC are viable if accompanied by a compensatory mutation in U2 
that restores helix Ib, but some substitutions such as G60Y cannot be 
suppressed in this manner (62).  A similar AGC motif in domain 5 of group II self-
splicing introns acts as a metal binding site crucial for catalysis (63) and, as 
noted by Hilliker and Staley, spliceosomal AGC mutations that cannot be 
suppressed by U2 are expected to interfere with metal binding. 
 
A second metal bound in domain 5 of group II introns is thought to mediate a 
docking interaction (63), and again an analogous metal binding motif exists in the 
ISL of U6.  U80 (Throughout all sections of this work, S. cerevisiae numbering 
will be used unless otherwise specified) is bulged from the ISL and binds 
magnesium (64).  The formation of this U80 bulge occurs after U4/U6 unpairing 
(5), and suppression data indicate the delicate balance of relative stabilities 
required to allow both structures to form, and thus permit splicing (65).  However, 
the importance of specifying not only the nature but also the precise timing of 
interactions within the spliceosome is illustrated by the complex behaviour of this 
nucleotide.  When substituted by 4-thio-uridine, U80 forms a site-specific 
crosslink with a nucleotide well upstream of the branch site of actin pre-mRNA 
(66); in addition, an Fe-BABE group tethered at the presumably fairly innocuous 
+10 position of the 5’SS stimulates cleavage at the human equivalent of U80 
(67).  Although it is possible that these biochemical data correspond to off-
pathway intermediates, it is also plausible that they indicate that at least some of 
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the groups responsible for catalysis are sequestered by other interactions until 
the immediate pre-catalytic state of the spliceosome. 
 
Spliceosome conformations can also be affected by transient protein 
modifications.  For example, in addition to the known effects of the 
phosphorylation state of SR and other proteins on spliceosome assembly, 
Snu114 and the U2 snRNP protein SF3b155 appear to be dephosphorylated for 
the second step of splicing (68) and references therein).  Similar effects are likely 
to be uncovered for many splicing factors, and indeed Prp8 ubiquitinylation has 
recently been shown to affect spliceosome assembly (69) 
ATPASES AND FIDELITY 
Although the short duplexes involved in spliceosome assembly and catalysis may 
be able to unwind naturally to facilitate conformational changes, perhaps in 
concert with other remodelling events, DExD/H ATPases represent a major class 
of spliceosomal proteins; by stimulating conformational transitions within the 
spliceosome, these ATPases play an integral role in the maintenance of splicing 
fidelity.  Prp16, which as previously noted facilitates opening following the first 
step, was isolated as a suppressor of a branch site mutation in S. cerevisiae, and 
the relaxation of the requirement for adenosine at the branch site was 
subsequently shown to be due to ATPase impairment, resulting in the kinetic 
proofreading model of splicing fidelity (70).  According to this model, functional 
progression into the second step occurs if catalysis precedes Prp16 ATP 
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hydrolysis, whereas substrate discard results if catalysis has not occurred before 
ATP hydrolysis.  ATPase-deficient prp16 alleles reduce fidelity and suppress 
splicing defects by allowing more time for catalysis to occur, resulting in the 
progression of suboptimal substrates, which would otherwise be discarded, 




Figure 1-5. NTPase-associated steps during splicing as opportunities for 
kinetic discrimination.   
(Upper) Schematic of transitions facilitated by DExD/H-box ATPases and the 
Snu114 GTPase during pre-mRNA splicing.  SS, splice site; BS, branch site.  
(lower) Characterised examples of kinetic proofreading mediated by 
spliceosomal ATPases: (left) Altered competition between BS-U2 pairing and the 
conformational change mediated by the Prp5 ATPase changes the fidelity of BS 
selection.  (center) Altered competition between the first catalytic step and Prp16 
ATPase activity affects the fidelity of splice site usage in this step.  (right) Altered 
competition between the second catalytic step and Prp22 ATPase affects second 
step splice site fidelity. 
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An important prediction of the kinetic proofreading model is that each ATPase-
mediated conformational change affords opportunity for such a 
progression/discard branch in the splicing pathway: recent work has indeed 
demonstrated analogous behaviour for two more spliceosomal ATPases, 
consistent with the generality of this mechanism.  S. cerevisiae spliceosomes 
assembled on 3’SS mutant substrates and purified after the first step proceed 
through the second in the presence of mutant Prp22 protein deficient for ATPase 
and/or unwindase activity, or in the absence of ATP (Fig. 1-5) (71).  Genetic work 
in S. cerevisiae has also shown kinetic proofreading of branch site-U2 snRNA 
interaction by Prp5 (Fig. 1-5).  ATPase-deficient prp5 alleles suppress mutations 
flanking the BS that destabilise its pairing to U2, but suppression can be 
superseded by re-stabilising this interaction, either by compensatory mutations in 
U2 or intron mutations that generate extra upstream base pairs.  The level of 
suppression by prp5 alleles correlates inversely with their ATPase activity.  Prp5 
proteins from organisms in which the branch site is less highly conserved than in 
S. cerevisiae have lower ATPase activity, thus providing a mechanism by which 
the fidelity of branch site selection is reduced in these organisms (36).  This work 
identifies the first structure to be in direct competition with the activity of a 
spliceosomal DExD/H ATPase, but the precise molecular consequences of 




The kinetic proofreading model holds that the conformational change mediated 
by each ATP hydrolysis event is in competition with the preceding step on the 
splicing pathway.  ATP hydrolysis results in progression through the pathway if 
the preceding step has been completed, and otherwise in substrate discard (36, 
51, 71).  Optimal substrates, which interact most favourably with the catalytic 
centre and therefore undergo each step of the splicing reaction more quickly than 
suboptimal substrates, are thus selectively driven through the reaction.  Kinetic 
proofreading, if the catalytic rates of the ATPases in question are sufficiently 
high, allows the extent of spliceosome assembly and catalysis on suboptimal 
substrates to be minimised, as only optimal substrates will react quickly enough 
to compete with ATP hydrolysis.  As the rate of ATP hydrolysis decreases, the 
ratio of discard to progression (predominantly on suboptimal-, but also on optimal 
substrates) decreases as substrates are afforded more time to assemble/react.  
 
In the extreme case of zero ATPase activity, the reversibility of splicing (59) will 
likely allow equilibrium to be reached prior to the spontaneous occurrence of 
spliceosomal transitions.  Because spliceosomal complexes containing optimal 
(and optimally reacted) substrates will be more stable than those containing 
aberrant substrates/products, the most populated intermediates at equilibrium will 
be those corresponding to assembly and catalysis on such optimal substrates.  
The equilibrium scheme will therefore favour the use of intrinsically strong splice 
sites to an extent determined by the difference in binding energy between the 
relevant wild-type and cryptic sites.  Although it is therefore theoretically possible 
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to use reversibility and the resulting equilibrium as a slow proofreading 
mechanism, this is normally precluded by ATPase-mediated introduction of 
forward ratcheting and discard into the splicing pathway.  In certain situations, 
however, equilibrium-based maintenance of splicing fidelity may be 
advantageous.  Metazoan genes can be extremely long: a well-known example is 
the human dystrophin gene, which gives rise to a 14kb mRNA, is 2.3 Mb long 
and has 79 exons that are spliced during the 16 hours required for its 
transcription (72).  In the context of such a long timeframe and energetically 
costly transcript, it is conceivable that rapid splicing with the concomitant risk of 
discard is disfavoured, and that local ATPase concentration/activity may be 
downregulated such that splicing events lie closer to equilibrium and fidelity is 
maintained by reversibility.  It is worth noting that upregulation of ATPase activity 
could act as an effective and rapidly activatable transcriptional attenuator in this 
system, as discard between the catalytic steps would cleave the nascent 
transcript.  At the other end of the spectrum lie ribosomal protein and other highly 
transcribed genes, especially those in rapidly dividing cells: for such genes, the 
energetic waste associated with substrate discard is likely outweighed by the 
greatly increased rate of splicing facilitated by ATPases, and thus the more rapid 
production of functional pre-mRNA. 
 
Most spliceosomal ATPases are currently thought to facilitate a single transition 
along the splicing pathway, although the example of Brr2 demonstrates the 
possibility of a single ATPase acting multiple times (Fig. 1-5).  The question of 
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how ATPase activity is limited to the correct stage(s) remains an open one.  
Binding of one ATPase to the spliceosome is not necessarily mutually exclusive 
with the presence of others, as illustrated by the persistent presence of Prp43 
from early complexes until disassembly (6) during which time many other 
ATPases act.  It is, however, possible that the binding sites for some ATPases 
share common elements, such that mutually exclusive subsets exist.  A 
requirement for cofactors to stimulate ATPase activity is one mechanism by 
which activity could be temporally regulated: the helicase activity of Prp43 is 
stimulated by Ntr1, and this stimulation is required for Prp43’s role in 
spliceosome (73).  The recruitment of a cofactor or, in the event of an ATPase 
interacting with multiple spliceosomal components, the conformation of the 
spliceosome itself, could therefore activate an individual ATPase among several 
simultaneously bound, and repress others such that inappropriate conformational 
changes are not induced.  The recent demonstration that Brr2’s helicase activity 
is activated by the C-terminal domain of Prp8 (74) supports the hypothesis that 
ATPases may be activated by specific spliceosomal conformations, as Prp8 is 
without doubt associated with the spliceosome from tri-snRNP recruitment 
onwards. 
 
Reversal of both steps of splicing catalysis by the spliceosome demonstrates the 
possibility of undergoing the transition between the two chemical steps of splicing 
(albeit in reverse) in the absence of Prp16, the ATPase normally responsible for 
this transition.  There are two potential mechanistic interpretations of this Prp16-
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less reversal.  It is possible that Prp16 normally promotes transition into the 
second step by destabilising the first step conformation of the spliceosome.  
Because the reverse splicing reactions described by Tseng and Chen (59) 
contain neither Prp16 nor ATP, such reversal would be favoured and would 
therefore represent the truly spontaneous transition from the second to the first 
step.  It is also possible, however, that ATPase binding and/or ATP hydrolysis 
may act to facilitate spliceosomal transitions by the stabilisation of transition 
states along the splicing pathway.  In the event that Prp16 stabilised a transition 
state between the first and second step conformations, it is possible that its 
absence for the second-to-first-step transition may be partially complemented by 
the presence of Prp22, the ATPase normally required for the second catalytic 
step and mRNA release (75).  The existence of at least some shared binding site 
elements for Prp16 and Prp22, as would be required for such complementation, 
is supported by the lack of temporal overlap in the binding of these two ATPases 
(76). 
 
Substrate discard, while detrimental to the generation of mature mRNA, can play 
important physiological roles.  The spliceosome is ideally suited to generate 
precise 3’ ends possessing terminal hydroxyl groups, as such RNAs are a normal 
product of the first catalytic step.  Recent work from Baumann and co-workers 
(77) indicates that the 3’ end of telomerase RNA, TER1, in S. pombe is 
generated by spliceosomal processing: mature TER1 in this organism is in effect 
a free 5’ exon that has been discarded by the spliceosome prior to the second 
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catalytic step.  The precursor RNA from which mature TER1 is produced 
contains an intron with an inefficiently used 3’SS; strengthening this 3’SS 
reduces the level of mature TER1 as a direct result of an improved second step 
of splicing, and leads to a decrease in telomere length.  Although in this instance 
the dominant effect appears to be due to weak splice sites, it is possible that 
other cis-acting sequences are present that, directly or via other trans-acting 
factors, enhance substrate discard.  The generation of functional cellular RNAs 
via first step catalysis and discard by the spliceosome may not be limited to S. 
pombe telomerase: virtually any RNA requiring a defined 3’ end could be 
produced via such a mechanism.  We note that splicing, with or without discard, 
could also serve as a means to generate lariat RNAs; although evidence for 
biological roles for such RNAs is lacking, they could for example serve to protect 
transcripts from exonuclease digestion, or to generate RNAs lacking 5’ ends, 
which could presumably remain stably un-capped. 
 
Many important mechanistic questions regarding the role of DExD/H-box 
ATPases in the maintenance of splicing fidelity remain to be addressed.  As will 
be discussed in chapter 5, the direct targets of these ATPases remain to be 
identified.   Another open question is the nature of the discard possible at each 
ATPase-mediated step, which remains enigmatic.  It is possible that the 
conformational change resulting from ATPase activity is not compatible with 
binding of the substrate for the previous step, such that it would cause the 
spliceosome to fall apart: alternatively, an active disassembly cascade could be 
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triggered by such a conformational change.  It is even possible that the 
spliceosome may need to undergo several conformational changes resembling 
functional progression along the splicing pathway in order to allow discard.  A 
role in discard for Prp43 and Ntr1, which cooperate in spliceosome disassembly 
(78), might suggest that discard is mechanistically similar to progression.  Some 
support for this model is provided by the observation that discarded 
intermediates are degraded in the cytoplasm (79); this finding implies that 
discard, like mRNA release, is coupled to nuclear export.  
THE SECOND CATALYTIC STEP 
The second step of splicing remains substantially less well-characterised than 
the first.  In addition to early recognition at the stage of complex A formation, the 
3’SS has been proposed to be selected after the first step via a simple scanning 
mechanism as the first AG dinucleotide, or the second if sufficiently close to the 
first AG, downstream of the branch site (yeast) or polypyrimidine tract (metazoa) 
(80-82).  Distance from the branch site is an important determinant of 3’SS 
strength: Prp22, Slu7 and Prp18 are all dispensable in vitro for introns with short 
BS-3’SS distances (75) and references therein), and Prp22 mutants stimulate the 
use of non-AG splice sites closer to the branch (71).  In addition, the splicing of 
genes with short BS-3’SS spacing is unaffected by knockout of the second step 
factor Prp17 in S. cerevisiae (83).  Aside from proximity to the branch site or 
polypyrimidine tract, what constitutes a favoured 3’SS remains unclear.  The 
YAG 3’SS consensus sequence has not been extended by bioinformatic 
30 
investigation, although it seems possible that local RNA structure may play a role 
in determining the quality of a 3’SS for the second step; such bioinformatics, 
along with genetic screens to search for possible determinants of YAG strength, 
may reveal higher complexity. 
 
Experimental investigation of the second step is hindered by several factors: the 
apparent ability of the spliceosome to assemble on one 3’SS and use another on 
the same pre-mRNA is one such hindrance.  Previously noted experiments in 
plants demonstrating that a 3’SS sequestered in a hairpin could act as a splice 
acceptor only in the presence of a downstream 3’SS suggested the possibility of 
re-specifying the 3’SS after early assembly (28).  Work on autoregulatory splicing 
by sex-lethal in Drosophila has provided evidence that a 3’SS can play a critical 
role in exon definition but not be preferred for catalysis (84).  It is therefore 
possible that 3’SS requirements for assembly and catalysis are, from an 
experimental point of view, at best not necessarily identical and at worst 
obligately distinct.  An ‘ideal’ 3’SS could thus represent a balance between 
assembly-competent and catalytically favoured states; this, and potential effects 
due to the almost unavoidable presence of nearby AG dinucleotides in natural 
genes, must be taken into account in any systematic analysis of 3’SS quality. 
 
A second obstacle to the investigation of the second step is that any active site 
component required for both steps will presumably exert its effects at the stage of 
first step catalysis, thus rendering the investigation of its role in the second step 
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technically difficult.  Although many spliceosomal components involved in the 
second step are dispensable for the first, such as the 3’SS itself (85), Slu7 (86) 
and loop 1 of U5 snRNA (87), several shared active site components might exist.  
Indirect information about the components of the second step active site could be 
derived from knowledge about the second step binding site of the lariat branch.  
The branch structure of the lariat intermediate must be repositioned and bound 
during the second step, consistent with the second step defect of 5’SS and BS 
mutants being suppressed by spliceosomal alleles that improve the second step 
(44, 46, 71).  Although the 5’SS portion of the branch structure appears to 
reposition relative to U6 as previously discussed, the nature of this interaction, as 
well as the fate of branch site pairing to U2 snRNA after first step catalysis, is 
unknown. 
 
In fact, temporal epistasis – that is, the manifestation of mutations that cause 
multiple sequential defects in a pathway only at their earliest point of action – can 
also impede the study of first step catalysis due to the long preceding assembly 
phase.  Systems in which assembly can be bypassed, at least in part (71, 81, 88, 
89),  could represent possible ways to circumvent this problem. 
 
Many proteins join the spliceosome between the two catalytic steps (6).  In vitro 
depletion/reconstitution studies, together with genetic work in vivo, have provided 
clues as to the function of many second step factors.  Loop 1 of U5 snRNA 
appears to act as a ‘platform’ on which the 5’ and 3’ exons are juxtaposed for 
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ligation (42), and interacts functionally with Prp18 – a protein that also binds Slu7 
(90).  Slu7 depletion leads to a loss of 3’SS fidelity, and also appears to 
destabilise free 5’ exon binding to the pre-second step spliceosome (91).  Prp22 
crosslinks directly to the 3’SS following the action of Prp16 (92) and is also 
involved in mRNA release (75, 93).  Interestingly, although all of these factors are 
essential in vivo, the requirement for each can be at least partially bypassed in 
vitro (42, 75, 91, 94), suggesting both that the second step spliceosome is fairly 
robust, and that these factors do not form interactions strictly necessary for 
catalytic events.  Instead, a likely possibility is that they all contribute to 
stabilisation of the second step conformation relative to the first.  Elucidation of 
the interactions made by these factors will be necessary to understand how they 
can impact 3’SS use and therefore alternative splicing. 
ALTERNATIVE SPLICING 
In the absence of repression, strong splice sites give rise to constitutive splicing; 
alternative splicing therefore represents the suppression of optimal splice sites 
and/or the use of those that are suboptimal.  Most alternatively spliced introns 
are thought to be controlled by multiple splicing enhancer and silencer elements 
whose activity depends on their location relative to splice sites; these regulatory 
elements are thought to affect splicing predominantly through corresponding 
RNA binding proteins that exert their effects by altering a specific step in the 
spliceosome assembly pathway (95).  However, modulation of splicing efficiency 
is theoretically possible at any stage of the splicing reaction.  Each splicing event, 
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depending on the introns and exons involved, will be limited by one or more 
transitions, and will as such be sensitive to modulation of their efficiency while 
being insensitive to all but the most major changes in that of non-limiting steps.  
Given the diversity of pre-mRNA substrates, the multi-step nature of the 
spliceosome assembly and catalysis pathway, and the enormous number of 
factors involved in the splicing of every transcript, it is almost certain that 
examples exist in nature of splicing regulation at every possible stage.  The 
existence of natural splicing events at least partially limited by post-assembly 
transitions has already been demonstrated: the splicing of overlapping but non-
identical sets of endogenous introns is sensitive to the knockdown or mutation of 
core spliceosomal proteins important for the catalytic phase of the reaction (96, 
97); this sensitivity affords opportunities for splicing regulation during catalysis.  
The ability to regulate the splicing of an individual intron by modulating the local 
activity or concentration of a given protein, or that of a class of introns via more 
global changes, together with the combinatorial effects of regulation of multiple 
transitions, can allow the robust and specific regulation of splicing events without 
a requirement for large numbers of individual splicing factors to exert this control.  
Thus, in order to understand alternative splicing, specific factors acting on each 
transcript need not necessarily be sought, and the entire reaction through 
assembly, catalysis and disassembly must be considered. 
 
The stimulation or repression of spliceosome assembly naturally represents a 
common mechanism of splicing regulation, and may indeed be the most 
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prevalent in higher eukaryotes.  Such assembly-based regulation might, 
however, be more subtle and complex than commonly thought.  Virtually all 
metazoan transcripts contain multiple sequences capable of being recognised 
and used as splice sites, and much silencer-based repression may therefore 
require kinetic competition between these sites, serving predominantly to redirect 
rather than strictly to repress spliceosome assembly and/or catalysis. 
 
Alternative splicing has not conventionally been considered to occur in S. 
cerevisiae.  Data showing that the splicing of meiosis-specific genes is activated 
during meiosis (98) through the action of the Mer1 and Snu56 proteins (99), 
however, identify a system in which true alternative splicing can indeed be 
observed in this organism.  We also note with interest the recent demonstration 
that the SR-like protein Npl3 activates the splicing of ribosomal protein genes, 
apparently via the recruitment of U1 and/or U2 snRNPs to sites of transcription 
(100); this behaviour is reminiscent of aspects of mammalian SR protein action.  
In spite of its relative paucity of natural alternative splicing events, S. cerevisiae 
represents the ideal model organism in which to carry out mechanistic splicing 
research in vivo; its ease of genetic manipulation and strong splice site 
consensus requirements allow many different events in splicing to artificially be 
made limiting for gene expression, facilitating detailed mechanistic analysis of the 
suboptimal splice site use that underlies alternative splicing. 
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CONCLUDING REMARKS 
Enormous amounts of data exist regarding regulated and cell-type-specific 
splicing patterns (101).  Specific splicing factors that affect the splicing of small 
numbers of transcripts must exert their effects via spliceosomal transitions and 
through core components, both of which are finite in number.  This imposes a 
limit on the number of possible unique mechanisms of splicing regulation.  In 
addition to the discovery of more specific splicing factors, we anticipate that more 
widespread and varied regulatory roles will be discovered for core spliceosomal 
components themselves.  A clear, mechanistic description of the splicing process 
is necessary to explain regulated splicing, and the detailed analysis of various 




CHAPTER 2. AN ATTEMPT TO RECAPITULATE S. CEREVISIAE 




The question of whether the active site of the spliceosome is composed partly or 
entirely of RNA, like that of the ribosome (102), remains unresolved (103, 104).  
Prompted by the demonstrated ribozyme activity of U6 snRNA-derived 
sequences (105, 106) and the observation that RNAs with sequences based on 
those of human snRNAs and splicing substrates can form covalent bonds in vitro 
(89, 107, 108), we sought to investigate whether S. cerevisiae snRNAs would 
show such reactivity.  S. cerevisiae is deficient in SR proteins, which stimulate 
splicing in metazoan systems at least in part via the stabilisation of RNA-RNA 
interactions (38, 39), and its spliceosome therefore relies more heavily on the 
intrinsic stability of these interactions than do those of higher eukaryotes (2). We 
reasoned that yeast snRNAs and splicing substrates may represent the optimal 
basis for a protein-free system to study pre-mRNA splicing.   
 
One common issue with RNA-based systems, however, is the intrinsically 
reactive nature of RNA: reactions such as self-cleavage (109) and uncatalysed 
RNA ligation (110) are commonplace and may have simple, or even no, 
structural requirements.  This chapter describes the positionally specific and 
relatively efficient formation of a 2’-3’ bond between nucleotides in linker regions 
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in our original snRNA- and branch-site-based constructs.  The formation of this 
non-physiological bond does not require snRNA sequence beyond that required 
for substrate binding, and can be observed using two short synthetic RNA 
oligonucleotides containing a minimal hairpin motif.  These results reiterate the 
reactivity of RNA towards phosphate transfer reactions and suggest that a large 
amount of potentially reactive RNA sequence space is likely to be explored in 
cells.  The manner in which this ribozyme activity was identified also highlights 
both the need for more stringent characterisation and validation of RNA-only 
reactions currently interpreted as indicative of ribozyme catalysis by the 




AN RNA BASED ON FUSED S. CEREVISIAE U2 AND U6 SNRNA 
SEQUENCES SLOWLY FORMS A COVALENT BOND WITH A BRANCH SITE 
OLIGONUCLEOTIDE IN VITRO 
In order to investigate the possibility that S. cerevisiae snRNAs may be able to 
catalyse reactions similar to those observed with human snRNAs (9, 107, 108), 
we generated a construct comprising the 5’ terminal 46 nucleotides of U2 snRNA 
fused to the 3’ portion of U6 snRNA beginning at position G39, hereafter referred 
to as U26.  The two snRNAs were joined via a loop of four uridine residues, and 
two extra G-C base pairs were added around this loop to encourage 
intramolecular folding (Fig. 2-1A).  This construct was mixed at ~1 µM with a 
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labelled oligonucleotide corresponding to the canonical S. cerevisiae UACUAAC 
branch site sequence with additional nucleotides upstream to stabilise binding to 
U2 snRNA, and an unlabelled 5’ splice site (5’SS) oligonucleotide with similarly 
hyperstabilised binding to U6 snRNA in the register required for the first step of 
splicing (Fig. 2-1A) (37, 111, 112).  The RNA mixture was heated to 95˚C then 
slowly cooled to room temperature in 50 mM Tris-HCl pH 7.2 containing 40 mM 
MgCl2 and 200 mM KCl, left to react at room temperature, ethanol precipitated 
and analysed in a denaturing 20% polyacrylamide gel.  A time course showed 
the slow generation of a specific low-mobility band over the course of many 
hours (Fig. 2-1B); the formation of this band was unaffected by the location of the 
label (5’ phosphate or 3’ pCp) on the BS RNA and by the presence or absence of 
the 5’SS RNA (Fig. 2-1C), indicating that it contained the entire BS and no 5’SS 
sequence.  The slow mobility of the product suggested that it likely contained 
some or all of U26.  We therefore carried out RNase H degradation on the 
purified product using oligonucleotides directed against either end of U26, and 
observed an increase in mobility with an oligo against the 5’, but not the 3’ end 
(Fig. 2-1D).  The product therefore retains the 5’ end of U26 but has lost the 3’ 
end.  Taken together, these observations are suggestive of a reaction between 
an internal nucleophile in BS and an internal phosphodiester bond in U26.  
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Figure 2-1.  Slow formation of a covalently linked product containing the 5’ 
end of U26 and both ends of a branch site oligonucleotide. 
(A) Schematic of constructs based on S. cerevisiae snRNAs and splicing 
substrates: U6 snRNA sequence is shown in green, U2 snRNA sequence in red, 
and splicing substrates in black.  Potential base pairs, even when mutually 
exclusive, are indicated.  (B) The substrates depicted in Fig. 1a form a slowly 
migrating product over the course of several hours.  (C) Product formation does 
not depend on the presence of the 5’SS oligonucleotide, and the product 
contains both ends of the BS oligonucleotide.  (D) RNase H digestion of purified 
product with oligonucleotides complementary to the 5’ or 3’ ends of the U26 
construct indicates that the product contains the 5’-, but not the 3’ end, of U26. 
 
CONSERVED U6 SNRNA SEQUENCES ARE NOT REQUIRED FOR 
REACTIVITY TOWARDS BS 
The single sharp band observed following reaction of BS and U26 suggested a 
positionally specific reaction. In addition, the observed internal cleavage of U26 is 
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suggestive of a transesterification; we therefore wished to investigate the 
dependence of our observed reactivity on snRNA sequences known to be 
important for pre-mRNA splicing.  We generated constructs in which either or 
both of the ACAGAGA and AGC motifs in U6, which are universally conserved 
and essential for viability (2), were mutated to runs of adenosine residues (Fig. 2-
2A).  The reactivity of these constructs was indistinguishable from that of U26 
containing wild-type ACAGAGA and AGC (Fig. 2-2B).  In addition, we made a 
series of deletion constructs in which U26 was truncated from its 5’- (Fig. 2-2C 
Δ1-3) or 3’ ends (Fig. 2-2C, Δ4-6) and expressed from a cloning vector (pDrive, 
Qiagen).  U26 RNAs truncated at their 5’ ends showed strong reactivity until most 
of the BS binding site had been removed (Fig. 2-2D lanes 2-4), with further 
truncation presumably precluding binding of the BS oligonucleotide.  3’ end 
truncations/substitutions removed U6 sequence upstream of a constant vector 
sequence preceding a T7 terminator.  Truncations beginning at and downstream 
of ACAGAGA retained reactivity (Fig. 2-2D cf. lanes 1 & 5-6), and a construct 
containing only two nucleotides of U6 sequence still produced a trace amount of 
product (Fig. 2-2D lane 7).  The mobilities of products derived from truncated 
U26 molecules are consistent with retention of only the 5’ end of the molecule; 
this rules out a 2’-5’ linkage and, consistent with this, the mobility of the product 
was not affected by treatment with recombinant debranching enzyme (data not 
shown).  The reactivity of these truncation constructs also suggests 
(conservatively) that the scissile bond in U26 lies between positions G37 of U2 
and C48 of U6.  Subsequent experiments were therefore performed with a 
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synthetic RNA oligonucleotide corresponding to the region of U26 from U2 
position G37 to U6 position C48 (Fig. 2-3A). 
 
 
Figure 2-2. Virtually no snRNA sequence is required for U26 reactivity. 
(A). Schematic indicating mutations in the ACAGAGA and AGC motifs of the U6 
portion of the U26 construct: these motifs are universally conserved and 
essential for viability.  (B) Mutation of either or both of the ACAGAGA and AGC 
motifs to runs of As has no effect on the formation of the U26-BS product.  (C) 
Schematic indicating truncations made from the 5’ end (1-3) or 3’ end (4-6) of the 
U26 construct.  These truncations were made in the context of constant 
surrounding vector (pDrive, Qiagen) sequence.  (D) Some truncated U26 
constructs retain reactivity towards BS.  Deletion construct 6 shows little 
reactivity, and construct 3 none, the latter likely due to an inability to bind the BS 
oligonucleotide.  The observed variation in product size is consistent with 











Figure 2-3.  Identification of the reactive site on the BS oligonucleotide. 
(A) Schematic indicating the sequences of constructs used in this figure.  (B) The 
2’ hydroxyl of the 5’-terminal nucleotide of BS is strictly required for reactivity 
towards U26.  BS oligonucleotides with diverse 5’ ends can react; reaction 
efficiency varies with the identity of this nucleotide, but not in a manner 
consistent with a functional group from the base acting as a nucleophile.  
Reactivity is not due to a synthesis artefact, as oligonucleotides made via 
different synthesis routes (TBDMS and 2’ ACE) react with identical efficiency.  
(C) TLC characterisation of the product: (i-iv) 2-D TLC analysis of P1 
nuclease/RNase T2 digestions of unreacted BS substrate (i, iii) or reaction 
product (ii, iv) with a labelled 5’ terminal U.  The migration of unlabelled markers 
is indicated, and expected labelled digestion products shown.  BS-derived 
sequence is shown in black, and unmapped U26 sequence in grey.  (v) DEAE 
TLC analysis of P1 nuclease/RNase T2 digestions of the 5’U reaction products to 
assay net charge; the positions of an unlabelled pUp marker and markers 





THE PRODUCT COMPRISES THE ENTIRE BS RNA JOINED VIA ITS 5’-
TERMINAL NUCLEOTIDE TO A 5’ FRAGMENT OF U26 VIA A 2’-3’ 
PHOSPHODIESTER BOND 
Rough mapping by RNase digestion using internally labelled BS oligonucleotides 
suggested that the reactive group in BS was close to the 5’ end of the molecule 
(data not shown).  5’ end-labelled BS with a uridine as its 5’-terminal nucleoside 
was reacted with the minimal U26 oligonucleotide depicted in Fig. 2-3A, and this 
product gel-purified.  Purified BS-U2 product was digested to completion with P1 
nuclease, which cuts 5’ of each nucleotide to yield pN, or RNase T2, which cuts 
3’ of each nucleotide to yield Np, and pNp in the case of a phosphorylated 5’-
terminal nucleotide; digestion products were separated by two-dimensional thin 
layer chromatography as previously described (113).  The labelled phosphate 
from unreacted BS purified from the same gel as the product comigrated as 
expected with pU and pUp markers after P1 and T2 digestions, respectively (Fig. 
2-3C, i&iii).  P1 and T2 digestions of the BS-U2 product, however, produced 
species that did not comigrate with any of our mononucleotide markers, but 
which migrated similarly to one another (Fig. 2-3C, ii&iv).  Neither P1 nor T2 can 
cleave at a branch nucleotide (113), so the failure of these nucleases to produce 
labelled pU and pUp, respectively, from BS-U2 is indicative of branching from the 
5’-terminal nucleotide of BS.  Branching from further downstream nucleotides 
would not result in aberrant labelled P1/T2 digestion products.  While this initial 
TLC analysis did not clarify the nature of the covalent bond between BS and 
U26, we reasoned that the most parsimonious chemistry was a 2’-3’ 
phosphodiester bond between the 2’ hydroxyl of the 5’-terminal uridine of BS and 
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a phosphate group from U26.  Such 2’-3’ branched molecules would be expected 
to produce similar products on digestion with P1 nuclease/RNase T2 (these 
products are shown schematically in Fig. 2-3C, ii&iv).  Because the P1 and T2 
digestion products of such a BS-U26 product are expected to differ only in the 
location of a single phosphate group (Fig. 2-3C), they should carry an identical 
net charge of -6.  Further TLC analysis of the P1 and T2 digestion products using 
DEAE plates indicated that both did carry a -6 charge (Fig. 2-3C, v – the slight 
mobility difference is due to the 5’ or 3’ location of the unlabelled terminal 
phosphate); only a branched RNA molecule could carry more than four charges 
after P1 or T2 digestion, and only a 2’-3’ branch would generate P1 and T2 
digestion products with the same charge.  The bond between BS and U26 can 
therefore be assigned as a 2’-3’ phosphodiester.  We obtained analogous results 
for all mapping experiments using full-length U26 and a BS oligonucleotide with a 
5’-terminal G, indicating the generality of this product (data not shown).  
  
In addition to our TLC analysis, further data support the assignment of this 
reaction as a 2’-3’ transesterification.  The reaction proceeds regardless of the 5’ 
end phosphorylation state of the BS oligonucleotide (Fig. 2-1C), and a 5’-terminal 
phosphate on BS remains sensitive to phosphatase treatment in the product 
(data not shown); this rules out an involvement for the 5’ phosphate itself 
meaning that the nucleophile must either be a group on the 5’-terminal base or its 
associated ribose/phosphate.  Changing the 5’-terminal base of BS has a 
profound effect on reactivity (Fig. 2-3B lanes 1-4), with the 5’U being the most 
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reactive and the 5’G the least.  However, the relative efficiencies of reaction that 
we observe are inconsistent with attack by a functional group on the base, and 
we believe them to be related to a basic structural requirement for this reaction.  
Reactivity due to a contaminant or incompletely deprotected group arising from 
chemical oligonucleotide synthesis was ruled out by the identical reactivity of 
oligonucleotides produced via TBDMS and 2’ACE synthesis (Fig. 2-3B lanes 4-
5).  The 2’ hydroxyl of the 5’-terminal nucleotide therefore remains as the only 
possible nucleophile for this reaction.  Indeed, substitution of the normally 
reactive 5’ uridine with deoxyuridine abolished reactivity (Fig. 2-3B lanes 4 and 
6).   
 
Transesterification reactions are strongly dependent on metal ions, requiring 
divalent cations for nucleophile activation and leaving group stabilisation (114).  
Consistent with the BS-U26 reaction being a transesterification, no product is 
observed in the absence of divalent metal ions, but magnesium, manganese or 
calcium can all support reactivity (Fig. 2-4 lanes 10-13).  Two metal ion catalysis 
requires inner shell coordination of reactive groups by the divalent metal ion; 
such coordination is not possible with cobalt hexamine – a structural mimic of a 
fully hydrated Mg2+ - and the absence of reactivity in the presence of cobalt 
hexamine (Fig. 2-4 lane 14) therefore further supports the assignment of this 
reaction as a transesterification.  Finally, the increase in efficiency observed with 
increasing pH (Fig. 2-4 lanes 1-5) is suggestive of the expected requirement for 
nucleophile deprotonation.   
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Figure 2-4. pH and metal ion requirements of the reaction. 
pH and metal ion dependence of the reaction between [5’U] BS and the minimal 
U26 oligonucleotide. 
 
MAPPING THE SCISSILE PHOSPHATE WITHIN U26 
Together, our data demonstrate the formation of a 2’-3’ phosphodiester bond 
between BS and U26.  Such a bond is currently unprecedented in any 
physiological system, but has previously been observed in the products of 
artificial ribozymes (105).  Incompatible strand polarities precluded mapping the 
site of reactivity in U26 by primer extension, and the U26 concentrations required 
to generate detectable levels of product rendered specific labelling experiments 
impractical.  Indirect identification of the scissile bond was, however, possible via 
RNase digestion of products containing end-labelled BS. 
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Figure 2-5. Mapping the scissile phosphate in U26. 
RNase digestion of [5’U] BS (S) and its product with U26 (P) identifies 
5’YRRRN3’ as the 3’-most nucleotides of U26 appended to BS; the sequence of 
BS and the sizes of hydrolysis fragments are indicated beside the ladder in lane 
3.  BS sequence is shown in black, and U26 sequence in grey.  (B) Schematic of 
the reaction with sites of reactivity and polarity of phosphodiester linkages 
detailed. 
In order to allow mapping of the scissile bond within U26, purified product 
resulting from reaction between a 5’ uridine end-labelled BS and the minimal U26 
oligonucleotide was digested with RNases A or T1 (Fig. 2-5A).  Typically RNase 
T1 cuts 3’ of guanosines, but under our conditions of high enzyme concentration 
(presumably required due to secondary structure in the products) it cuts 3’ of all 
purines with only a slight preference for guanosine. T1 digestion of the product 
indicated that that U26 was joined to BS via a purine, as each band resulting 
from digestion of the product showed a decrease in mobility corresponding to 1nt 
relative to the analogous band resulting from the digestion of unreacted substrate 
(Fig. 2-5A, lanes 6&7 – digestion products are shown schematically beside the 
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gel).  Digestion of the product with RNase A, which cuts 3’ of pyrimidines, 
generated a species that migrated as a 7-mer (Fig. 2-5A lane 5).  Branching from 
the terminal U of BS would inhibit RNase A cleavage at this position, so the first 
cut in BS must be made 3’ of C4; therefore the 7-mer digestion product indicates 
that the last four most 3’ nucleotides of the retained U26 fragment must be (with 
the RNase A cleavage site indicated by an asterisk) 5’Y*RRR3’—2’BS (shown 
schematically in Fig. 2-5A).  The minimal U26 oligonucleotide contains only one 
YRRRN sequence – the UGGGA running from the terminal U of the U4 loop to 
U6 A40, indicating that the scissile phosphate is that between the third G and the 
A in this motif.  We therefore conclude that the U26-derived strand of the product 
comprises the entire U2 portion and the CCCUUUUGGG stem loop 
(reactants/products are shown schematically in Fig. 2-5B).  The released 3’ end 
of U26 is expected to migrate among degradation products, and can therefore 
not be followed. 
 
Despite the simple ionic requirements of this reaction (Fig. 2-4), and the ability of 
BS oligonucleotides with diverse 5’ ends to react (Fig. 2-3B), at least some 
degree of higher-order structure appears to be important.  Mutations in the 
hairpin region of the U26 oligonucleotide, including compensatory changes as 
well as those that disrupt the helix, strongly inhibit or abolish reactivity towards all 
tested BS substrates (data not shown), suggesting that the juxtaposition of 
nucleophile and electrophile requires structure beyond simple base pairing.  The 
sensitivity of the U26 hairpin to mutation precludes detailed analysis of such 
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structural requirements.  However, given that the 5’-terminal nucleotide (G) of BS 
is capable of pairing to the 3’-terminal nucleotide (C) of U2 sequence in U26 (Fig. 
2-1A), and that the reactivity of BS oligonucleotides correlates inversely with their 
ability to form a base pair at this position (Fig. 2-3B, lanes 1-4), we hypothesise 
that nucleophilic attack occurs when the 5’ end of BS is single-stranded.  
 
DISCUSSION 
IMPLICATIONS FOR THE POTENTIAL REACTIVITY OF CELLULAR RNAS 
The ease with which ribozymes, particularly those that catalyse RNA hydrolysis 
or transesterification reactions, can be generated by SELEX (115), suggests that 
a large proportion of RNA sequence space is at least minimally catalytically 
active.  Our data, which show the relatively efficient and positionally specific 
catalysis of a transesterification reaction, apparently by a small and simple 
structural motif, support this idea. 
 
The use of tiling arrays and deep sequencing has recently indicated that a 
greater proportion of many organisms’ genomes is transcribed than was 
previously thought (116); given the diversity of cellular RNA sequence that such 
widespread expression would generate, high intracellular RNA concentrations, 
and the potential for ribozyme catalysis by extremely simple structures, such 
intrinsic RNA catalysis may occur in vivo.  Cells have likely evolved mechanisms 
to prevent and/or mitigate the effects of inappropriate RNA reactivity in vivo.  
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These mechanisms may include evolutionary selection against catalytically active 
sequences or structures, the rapid turnover of RNA such that sufficient time is not 
normally allowed for catalysis, and the coating of RNA molecules with proteins 
such as hnRNPs.   It is, however, also possible that such ribozyme-generated 
RNAs may play physiological roles.  The analysis of such potential products, as 
well as of enzymes involved in their further processing or degradation, may be 
complicated in eukaryotes by the background of lariats arising due to pre-mRNA 
splicing, as these will comprise the majority of non-linear RNAs.  In addition, 
ribozyme-derived products may contain bonds (such as 2’-3’ phosphodiesters) 
that do not lend themselves to conventionally used mapping techniques. 
IMPLICATIONS FOR THE UTILITY OF PROTEIN-FREE SYSTEMS AS TOOLS 
TO STUDY PRE-MRNA SPLICING 
The ability of snRNA-derived RNA sequences to catalyse chemical reactions 
including 2’-5’ phosphodiester bond formation has previously been interpreted as 
strong evidence for ribozyme catalysis by the spliceosome (89, 106, 107).  The 
data in this chapter highlight the feasibility of direct and unambiguous 
characterisation of the products of such in vitro reactions: in addition, they 
caused us to reflect on the requirement for stringent validation of such systems, if 
such validation is indeed possible.  In order for experimental systems based 
entirely on RNA to live up to their stated promise as the basis for analysis of 
splicing catalysis, they must be fully validated.  Given that catalytic mechanisms 
cannot be proven but only disproven, such validation requires that protein-free 
systems be shown, as far as possible, to catalyse reactions identical to those of 
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splicing both in terms of chemistry and catalytic mechanism.  Both stringent 
characterisation of intermediates and products, and the concordance of results 
between protein-free and complete spliceosomal systems, are therefore required.  
The need for recapitulation of results from RNA-only reactions highlights in turn 
the pressing need for model systems in which the catalytic phase of splicing can 
be studied in a truly spliceosomal context.  
DEFINING AND VALIDATING RELATEDNESS TO SPLICING 
RNA is a structurally promiscuous polymer that contains diverse functional 
groups: as such, a single RNA sequence may have the potential to catalyse 
and/or participate in many reactions (117).  Because sensitive detection methods 
allow for the investigation of products formed in low yields and at slow rates, 
multiple products may appear on extended incubation of diverse RNA molecules 
(including but not limited to RNAs that are snRNA-derived).  Thus, early in the 
development of a minimised model system for pre-mRNA splicing, it will almost 
certainly be necessary to decide which reaction product one defines to be 
derived from a splicing-related reaction.  RNA-only systems that generate 
products with the same covalent linkages as those that result from spliceosomal 
splicing may merit study, and could serve as interesting models for RNA 
catalysis.  A shared chemical identity, however, does not necessarily indicate 
that the precise mechanisms by which two bonds are formed are identical.  The 
present definition of relatedness to splicing, and our incomplete knowledge of 
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contributors to spliceosomal catalysis, make it unclear whether conclusions 
drawn from protein-free splicing are truly applicable to the spliceosome. 
 
Relatedness of a ribozyme reaction to pre-mRNA splicing has conventionally 
been concluded from its sensitivity to mutation of the ACAGAGA and/or AGC 
motifs in the U6 snRNA (or its derivative) component of the reaction (89, 106, 
107).  Sensitivity to such mutations is, however, not necessarily indicative of 
direct similarity to either reaction of splicing.  Although these core motifs, which 
are shared between U6 snRNA and group II introns, have recently been 
demonstrated to form the basis of the group II intron active site (118), similar 
sequences are also found in other ribozymes believed to be unrelated to 
snRNAs, and the full details of the role(s) of ACAGAGA and AGC in both these 
ribozymes and the spliceosome remain unclear.  For example, in spite of its 
universal conservation, the AGC triad is remarkably mutable in S. cerevisiae, 
with all substitutions except A59U and G60Y viable either alone or in the 
presence of compensatory U2 snRNA mutations that restore a helical interaction 
(helix Ia) (62).  Backbone groups, rather than bases, coordinate metal ions; the 
results of sequence-based mutagenesis could reflect structural defects common 
to various RNA folds and must therefore be treated with caution.  
 
Group II self-splicing introns provide a natural precedent for RNA catalysis of the 
two chemical reactions of pre-mRNA splicing, and their well-established 
similarities and likely evolutionary relatedness to snRNAs (63), especially in light 
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of the recent group II intron crystal structure (118) provide strong support for the 
hypothesis that the spliceosome active site is at least partially RNA-based.  We 
note that, by the present definition of relatedness to splicing, group II introns 
qualify as a protein-free splicing system.  We therefore suggest that either group 
II introns provide a pre-existing and ideal protein-free system in which 
mechanistic studies of pre-mRNA splicing can be carried out, or that more 
stringent requirements must be applied for a reaction to be considered as 
sufficiently related to spliceosomal splicing to serve as a model: one requirement 
is similar dependence on divalent metal ions.  Magnesium has been directly 
demonstrated to be important for spliceosomal catalysis (119, 120), and further 
investigation should clarify the coordination and precise mechanistic roles of 
divalent ions in the spliceosome.  Similar metal ion dependence in protein-free 
systems must be considered a prerequisite for splicing-relatedness. 
 
Before sensitivity to the mutation of core motifs in U6 snRNA can be used to 
define a splicing-like reaction, the nature of the defects arising from such 
mutations within a truly spliceosomal context must be elucidated.  Subsequent 
work demonstrating that defects are mechanistically identical in spliceosomal and 
protein-free contexts would, we believe, provide evidence that the observed 
reaction resembled splicing.  Again, however, we note that this mechanistic 
identity may already exist between group II introns and the spliceosome. 
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THE SPLICEOSOME AS AN RNP 
The above discussion highlights the need to develop parallel, fully spliceosomal 
model systems for the study of splicing catalysis before the applicability of 
protein-free reactions (including those of group II introns) to splicing can be 
reliably assessed.  The protein component of the spliceosome should not be 
ignored despite its daunting complexity (6).  A large number of spliceosomal 
proteins are essential for cellular viability and splicing in vitro: while many play 
important roles in the conformational rearrangements required for productive 
splicing (reviewed in chapter 1) a growing body of evidence suggests that some 
spliceosomal proteins may have a function beyond simple scaffolding of a 
catalytic RNA core.  Several recent studies show that Prp8 has an RNase H fold, 
also found in integrases and transposases (121-123), that contacts the 5’SS at at 
least one stage of spliceosome function: this further highlights the need for 
caution in interpreting results from RNA-only systems in the context of 
spliceosomal splicing: a fuller treatment is given to this issue in chapter 5. 
 
Although snRNA-only splicing cannot demonstrate that the spliceosome is a 
ribozyme, a validated system might rapidly produce a number of hypotheses 
regarding spliceosomal catalysis. Given the importance of spliceosomal proteins, 
the parallel systems able to validate protein-free splicing and test these 
hypotheses would by necessity be based on at least predominantly intact 
spliceosomes. Thus, while protein-free splicing could conceivably raise 
interesting questions, the hypotheses thus generated must necessarily remain 
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un-validated until they are supported by data from a model that supersedes the 
snRNA-only reaction.  For this reason, the establishment of more complete 
spliceosomal models likely represents the most constructive avenue for future 





CHAPTER 3.  TRANS-SPLICING OF A REPORTER GENE TO U2 
SNRNA IN VIVO 
INTRODUCTION 
Pre-mRNA splicing can be considered as three broad phases, each comprising 
multiple steps: these phases are spliceosome assembly, splicing catalysis, and 
spliceosome disassembly/mRNA release.  Although the majority of work in the 
splicing field is focused on assembly, there is growing consensus that transitions 
during the catalytic phase can limit the rate and fidelity of the overall splicing 
reaction and act as potential points of regulation (96, 97). 
 
The nature of the two chemical reactions of splicing (113) and a model for the 
mechanism by which fidelity is maintained (51) were proposed twenty and fifteen 
years ago, respectively, yet, despite the more recent advances outlined in 
chapter 1, many details of splicing catalysis remain enigmatic.  The relative 
neglect of the catalytic phase is in part due to the complex assembly phase that 
precedes it, as many defects will manifest themselves during assembly and thus 
preclude the investigation of catalysis; this highlights the need for new 
experimental systems for the study of the catalytic phase of splicing.  The duplex 
between the BS and the highly conserved cognate region of U2 snRNA (124-
126), shown schematically in Fig. 3-1A, exemplifies a structure believed to be 
important in multiple aspects of the splicing reaction, whose investigation has 
been hindered by the limitations of current experimental models. 
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During spliceosome assembly, the BS is transiently bound by SF1/BBP before 
being transferred to U2 snRNA (127, 128).  The stability of the resulting BS-U2 
duplex is proofread by kinetic competition between duplex formation and ATP 
hydrolysis by the DExD/H box ATPase Prp5 (36), with sufficiently stable BS-U2 
interaction allowing progression into the productive splicing pathway as opposed 
to pre-mRNA discard.  Mutations that weaken the interaction between the BS 
and U2 therefore strongly inhibit spliceosome assembly. 
 
The BS-U2 pairing established during spliceosome assembly has generally been 
thought to persist unaltered through the first catalytic step of splicing.  As will be 
discussed in detail in the introduction to chapter 4, the catalytically relevant form 
of the branch nucleophile is thought to be that in which it is bulged from the BS-
U2 duplex (Fig. 3-1A), with this helix therefore playing a role in branch site 
specification and activation for catalysis.  No data exists regarding the fate of the 
BS-U2 duplex after branching catalysis has been completed: although, as 
discussed in chapter 1, the 5’SS portion of the newly formed lariat moves relative 
to U6 snRNA following the first step (44), the BS-U2 duplex has generally been 
assumed to persist unaltered through this transition even though this would 
presumably require movement of U2 relative to U6, likely resulting in the 
disruption of some intermolecular interactions formed between these snRNAs. 
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Figure 3-1. The BS-binding region of U2 snRNA contains multiple 5’SS-like 
sequences, and is the site of an intron in R. hasegawae. 
(A) Schematic of RNA-RNA interactions that contribute to the first step of 
splicing, with the initial G of each of the three 5’ splice site-like sequences in the 
BS-binding region of U2 snRNA indicated by circles. (B) Alignment of U2 snRNA 
sequences from various species.  The BS-binding sequence is indicated in red, 
and intronic sequence in blue: arrows point to potential 5’ splice sites 
 
As discussed in chapter 2, U2 and U6 snRNAs do appear to have some intrinsic 
catalytic potential, although it remains unclear whether this is related to splicing. 
In vitro-transcribed snRNAs, when incubated with a transcript containing a 
branch site sequence, induce the formation of a covalent bond proposed to be a 
phosphotriester between the canonical BS-A and the guanosine in the universally 
conserved U6 AGC triad (108).  This reaction may have some biological 
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relevance, as the site of reactivity in U6 is adjacent to the location of an intron in 
the S. pombe U6 snRNA gene (129), generally thought to have arisen due to an 
aberrant splicing event followed by retrotransposition of the resulting product into 
the genome. 
 
U6 reactivity in a spliceosomal context has in fact been observed directly (130).  
In an in vitro system designed to reconstitute nematode cis- and trans-splicing 
using Ascaris lumbricoides extracts, Nilsen and co-workers detected branched 
and linear RNA products indicating the use of U6 as both a branch acceptor and 
a 5’ exon in a 5’SS-independent splicing reaction.  The reaction appears to 
represent an aberrant first step followed by a quasi-normal second step, as the 
canonical BS and 3’SS nucleotides are used, and U6 mutants that abolish the 
ability to reconstitute normal cis- and trans-splicing also render U6 trans-splicing 
undetectable.  
 
Although U6 is the only snRNA that has previously been demonstrated to be 
reactive, the presence of multiple 5’SS-like sequences in the BS-binding region 
of U2 (Fig. 3-1A), and the presence of a spliceosomal intron close to this region 
in Rhodotorula hasegawae (131), (Fig. 3-1B) prompted us to search for the 
products of a trans-splicing reaction involving U2 in S. cerevisiae.  Described 
below is the characterisation of an RNA product comprising the highly conserved 
5’ end of U2 and the 3’ exon of the ACT1-CUP1 reporter gene in intact S. 
cerevisiae cells.  The formation of this product requires full spliceosome 
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assembly, and is only detectable when the reporter has a mutant 5’SS predicted 
to bind poorly at the spliceosome catalytic centre.  The predominant 5’SS used in 
U2 is in the middle of the predicted BS-U2 duplex, but multiple sites can be used; 
these data suggest that BS-U2 pairing is unlikely to be required for the second 
catalytic step of splicing, and that it may be at least partially disrupted prior to the 
first step. 
RESULTS 
THE BS-BINDING REGION OF U2 SNRNA CAN BE USED IN TRANS AS A 5’ 
EXON FOR BOTH STEPS OF SPLICING 
Attack of U2 snRNA by the branch site nucleophile would be expected to 
generate a truncated U2 molecule covalently linked via its new 5’ end to the 2’ 
hydroxyl of the BS, detectable as a strong stop by primer extension.  An initial 
screen for such branched derivatives of U2 snRNA in S. cerevisiae total RNA 
was inconclusive due to unavoidable low levels of degradation (data not shown), 
which precludes the assignment of stops as branches rather than hydrolysis 
products.  We therefore reasoned that any ‘free 5’ exon’ generated by such 
aberrant attack may be able to undergo the second step of splicing in trans to the 
3’SS of a reporter gene, generating a novel linear RNA detectable by RT-PCR.  
We performed nested RT-PCR on DNaseI-treated total RNA from strains 
carrying ACT1-CUP1 reporter genes (132) with various mutations, using 
antisense primers complementary to the CUP1 3’ exon and a sense primer 
corresponding to the 5’ end of U2 snRNA (Fig. 3-2A).  For multiple intron 5’SS 
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mutants (G1C, G1U, U2A, A3G, [A3C+U4A], G5A, G5C), we were able to detect 
a ~130 bp PCR product whose size corresponded to that expected for the ACT1-
CUP1 3’ exon appended to approximately 40 nucleotides of U2 (Fig. 3-2B, lanes 
2, 4, 5 and data not shown).  The 130 bp product was not generated from 
equivalent amounts of total RNA from strains carrying wild-type or 5’SS A3C 
ACT1-CUP1 reporter, both of which show an efficient first step of canonical cis-









Figure 3-2.  Trans-splicing in S. cerevisiae can generate an RNA comprising 
the 5’ end of U2 snRNA and the 3’ exon of a reporter gene. 
(A). Schematic of ACT1-CUP1 reporter pre-mRNA and U2 snRNA, indicating the 
mutations used in panels C and D, and the location of the RT and PCR primers 
(arrows) used in panel C. (B) RT-PCR using the primers indicated in Fig. 3-2A 
can amplify a product, of the size expected for a trans-splicing product generated 
using the BS-binding region of U2 as a 5’SS, from total RNA from S. cerevisiae 
Y04999 cells carrying reporters with 5’SS mutations as indicated.  (C) Primer 
extension analysis of RNA recovered from cells containing the ACT1-CUP1 
reporters as indicated. Primer complimentary to the 3' exon was used to reveal 
levels of pre-mRNA, mRNA, and lariat intermediate.  Strain Y04999 (Δdbr1) was 
used in order to accurately monitor the efficiency of the first step.  (D) The 130 bp 
RT-PCR product corresponds to trans-spliced U2-ACT1-CUP1. Reverse-
complemented sequencing trace from the purified 130 bp product.  U2 snRNA 
and ACT1-CUP1 sequence, as well as the chromatogram read, are indicated 
above the trace; concordance between chromatogram and gene sequence is 










Direct sequencing of the putative trans-splicing product indicated that it 
comprised the 5’-terminal 36 nt of U2 joined to the 3’ exon of ACT1-CUP1 (Fig. 
3-2D). The homogeneity of the sequencing trace indicates a strong splice site 
preference, with the wild-type ACT1-CUP1 3’SS and the A/GUAUCΨ site in U2 
(the best match in this region of U2 to G/GUAUGU, the S. cerevisiae consensus) 
apparently used substantially more efficiently than other sites.  
 
The trans-splicing reaction appears to be very inefficient, with steady state levels 
of the U2-ACT1-CUP1 product apparently lower than one molecule per cell 
based on RT-PCR standard curves (data not shown).  We estimate that, in the 
case of the G5A mutant, trans-splicing represents around one per hundred 
thousand two-step splicing events, comparable to the error rates of other 
macromolecular processes such as transcription.  
 
The generation of the U2-ACT1-CUP1 RNA by an aberrant but otherwise 
mechanistically normal splicing reaction should also produce a second species – 
a branched RNA comprising the 5’ exon and intron of ACT1-CUP1 joined via the 
2’ hydroxyl of BS-A to the 3’ 1139 nt of U2, and an intermediate consisting of the 
‘5’ exon’ portion of U2 with a 3’ hydroxyl; although we attempted to detect these 
products using RT-PCR- and Klenow-based methods, respectively, we were 
unable to do so.  This may in part be due to the rapid degradation of internally 
cleaved U2 snRNAs  (133). 
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TRANS-SPLICING TO U2 SNRNA REQUIRES POOR BINDING OF THE 
CANONICAL 5’SS AT THE SPLICEOSOMAL CATALYTIC CENTRE 
To investigate whether trans-splicing to U2 snRNA is simply a result of inhibition 
of the first step of the canonical splicing reaction, we analysed the effects of non-
5’SS reporter gene mutations on the efficiency of trans-splicing.  Mutations at 
and around BS (C256G, U257A, U257C, BS-C, BS-G – Fig. 3-3A), which virtually 
abolish productive splicing of the reporter transcript (Fig. 3-3C) did not promote 
trans-splicing (Fig. 3-3B, lanes 1-7). When combined with a 5’SS G5A mutation, 
which alone showed easily detectable levels of trans-splicing, diverse mutations 
at and around BS inhibited the trans-splicing reaction to the extent that the 
product was no longer detectable (Fig. 3-3B, lanes 15-19).  Even mutations that 
show only mild inhibition of the first step of canonical cis-splicing of G5A mutants, 
such as an extension of the pairing interaction between BS and U2 snRNA, 
abolished trans-splicing (Fig. 3-3B&C, lanes 15-16).  3’SS mutants exhibited 
behaviour identical to that of BS mutants, failing to promote trans-splicing in an 
otherwise wild-type reporter, and reducing it to undetectable levels in the context 
of a G1C mutation (data not shown).  BS and 3’SS mutations exacerbate the 
inhibition of canonical mRNA splicing caused by the G5A mutation (Fig. 3-3C, 
lanes 15-19 and data not shown), so their failure to further stimulate the aberrant 
trans-splicing reaction indicates that the requirements for this reaction extend 
beyond simple first step inhibition. 
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Figure 3-3.  Trans-splicing does not occur in reporter genes with mutations 
outside the 5’SS. 
(A) Schematic of ACT1-CUP1 reporter pre-mRNA and U2 snRNA, indicating the 
mutations used in panels C and D, and the schematic location of RT and PCR 
primers (arrows) used in panel B.  (B) Mutations at and around the branch site do 
not stimulate trans-splicing in an otherwise wild-type context, and inhibit it in the 
context of an accompanying 5’SS mutation.  RT-PCR analysis of RNA recovered 
from Y04999 cells containing the ACT1-CUP1 reporters as indicated, as in Fig. 
3-2B.  (C). Primer extension analysis of RNA recovered from Y04999 cells 
containing the ACT1-CUP1 reporters as indicated, as in Fig. 3-2C. 
Even among 5’SS mutants, the degree of first step inhibition is not a good 
predictor of trans-splicing efficiency.  For example, splicing is much more strongly 
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inhibited by the 5’SS U2A mutation than by [A3C+U4A] (Fig. 3-2C, lanes 2 and 
4), yet the extent of trans-splicing to U2 snRNA is greater in the [A3C+U4A] 
mutant (Fig. 3-2B, lanes 2 and 4).  [A3C+U4A] has been shown to affect splicing 
predominantly by altering 5’SS binding at the catalytic centre of the spliceosome 
(44).  Formation of the observed U2-ACT1-CUP1 RNA therefore appears to 
result from the aberrant attack by BS on U2 in the presence of a 5’SS that is 
poorly bound within the spliceosome catalytic centre, rather than simply from an 
inefficient first step of splicing. 
THE FUNCTIONAL U2 SNRNA COMPONENT OF THE SPLICEOSOME IS 
THE SUBSTRATE FOR TRANS-SPLICING 
To verify that the U2 snRNA portion of the trans-spliced product was derived 
from the U2 component of a functional spliceosome (rather than, for example, a 
second molecule of U2 displacing the reporter gene 5’SS) we took advantage of 
previously characterised compensatory mutations in U2 and U6 snRNAs.  
Mutation of U6 positions 56 and 57 from AU to UA is lethal except in the context 
of the compensatory, and likewise lethal in isolation, AU to UA mutations at 
positions 27 and 28 in U2, predicted to restore pairing in helix Ib  (61) (Fig. 3-4A).  
S. cerevisiae U2/U6 double knockout strains were constructed in which plasmid-
borne copies of both wild-type and mutant U2, and either wild-type or mutant U6 
were present.  In these strains, the identity of the U2 snRNA component of 
functional spliceosomes is expected to depend on the identity of the U6 snRNA 
gene carried, i.e. spliceosomes in the strain with wild-type U6 should contain 
wild-type U2, and those in the strain with mutant U6 should contain mutant U2 
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(Fig. 3-4B&C).  In both cases, the pool of ‘free U2’, as well as early spliceosome 
assembly intermediates, should contain both wild-type and mutant U2.  The ‘wild-
type spliceosome’ and ‘mutant spliceosome’ strains were transfected with G5A 
ACT1-CUP1 reporter, and the U2-ACT1-CUP1 trans-spliced product from each 
strain amplified by RT-PCR.  Sequencing indicated that the U2 snRNA portion of 
the trans-spliced product differed as predicted.  The strain carrying a wild-type 
U6 snRNA gene generated a trans-spliced product in which U2 sequence was 
wild-type (Fig. 3-4D), and that carrying the mutant U6 snRNA gene generated 
product with mutant U2 sequence (Fig. 3-4E), indicating that the trans-splicing 
reaction involves nucleophilic attack of the U2 snRNA component of a fully 
assembled, catalytically competent spliceosome, and therefore of the BS-binding 
region of U2 to which BS was bound. 
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Figure 3-4.  U2 snRNA in functional spliceosomes is the substrate for trans-
splicing. 
(A). Compensatory U2 and U6 snRNA mutations used in panels C and D.  (B, C) 
Predicted behaviour of wild-type and mutant U2 snRNAs in strains carrying a 
wild-type [B] or mutant [C] U6 snRNA gene.  (D, E) The trans-spliced product is 
generated by attack of U2 snRNA in functional spliceosomes.  Reverse-
complemented sequencing traces from purified trans-splicing product from 
yCQ62 cells carrying G5A ACT1-CUP1 reporter, both wild-type and mutant U2 
snRNA genes, and a wild-type [D] or mutant [E] U6 snRNA gene.  Concordance 
between chromatogram and wild-type gene sequence is indicated by boxes, and 
the mutated/wild-type helix Ib U2 snRNA nucleotides highlighted. 
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SPLICING CAN OCCUR TO ALL THREE PREDICTED 5’SS IN U2 SNRNA 
Although direct sequencing of the purified trans-splicing product had indicated 
the preferred use of CAAGUGΨA/GUAUCΨ  as a 5’SS, and of the wild-type 
ACT1-CUP1 3’SS, we reasoned that the use of less-favoured sites may be 
apparent if individual DNAs were analysed.  We therefore cloned the product into 
the pDrive sequencing vector (Qiagen), and sequenced multiple clones.  As 
expected, the majority of these clones (9/13) had used the preferred 5’SS in U2; 
however, one had used the GΨ/AG site one nt upstream, two the GU/GU site a 
further two nt upstream of this, and one the AA/GU a further two nt upstream 
(splice site usage in U2 snRNA is shown in Fig. 3-5E).  All clones had used the 
wild-type ACT1-CUP1 3’SS.  Due to our inability to detect reaction intermediates, 
we do not know whether the levels of trans-spliced products reflecting the use of 
distinct 5’ splice sites within U2 snRNA indicate differences in the efficiencies of 
the first step, the second step, or both, for each potential 5’SS.  The 5’ splice 
sites observed to be used span half a helical turn of RNA: the use of such 
spatially disparate 5’ splice sites is inconsistent with nucleophilic attack by the 
canonical BS-A within an intact, unaltered and undisrupted BS-U2 duplex.  Given 
that, even in the context of BS mutations that dramatically reduce splicing 
efficiency (BS-C, BS-U), S. cerevisiae introns show a strong preference for 
branching from the mutated canonical BS nucleotide rather than the adjacent 
adenosine (134), at least some transient unwinding of the BS-U2 duplex seems 
more likely than aberrant attack by a non-canonical BS nucleotide. 
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Figure 3-5.  U2 snRNA sequence is a suboptimal 5’SS in the context of a 
reporter gene. 
(A). Schematic of ACT1-CUP1 reporter pre-mRNA and U2 snRNA, indicating the 
U2 sequence substitution into ACT1-CUP1 and 3’SS gAG/ mutation used in 
panels B and C, and the RT-PCR primers used in panel C.  (B) Primer extension 
analysis of RNA recovered from Y04999 cells containing the ACT1-CUP1 
reporters as indicated, as in Fig. 3-2C.  (C) Spliced ACT1-U2-ACT1-CUP1 
mRNA can be detected by RT-PCR (lane 3).  Wild-type mRNA is shown for 
comparison (lane 1).  (D, E) Schematic indicating 5’SS usage in U2 sequence in 
cis in the context of ACT1-U2-ACT1-CUP1 [D] and in trans in the context of U2 
snRNA [E].  n refers to the number of plasmids sequenced containing trans-
spliced product that had used the 5’SS indicated by the arrow above, and circles 
indicate the predominant 5’SS detected in directly sequenced PCR products. 
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THE BS-BINDING REGION OF U2, IN THE CONTEXT OF THE ACT1-CUP1 
REPORTER GENE, IS INEFFICIENTLY USED IN CIS AS A 5’SS AND SHOWS 
A 5’SS PREFERENCE DISTINCT FROM THAT OBSERVED IN TRANS-
SPLICING 
Given the tandem arrangement of three 5’SS-like sequences in the BS-binding 
region of U2 snRNA, and their use as 5’ splice sites in the context of reporter 
gene mutations such as [A3C+U4A] and G5A that do not dramatically reduce the 
overall efficiency of cis-splicing, we investigated the efficiency with which U2 
sequence could be used as a 5’SS in the context of the ACT1-CUP1 reporter.  48 
nt of reporter sequence around the 5’SS was replaced with sequence 
corresponding to the first 48 nt of S. cerevisiae U2 snRNA, such that the 
/GUAUCU 5’SS from U2 replaced the /GUAUGU 5’SS in the reporter (Fig. 3-5A).  
Primer extension analysis of total RNA from strains expressing these ACT1-U2-
ACT1-CUP1 constructs revealed that this U2-substituted 5’SS was used 
inefficiently (Fig. 3-5B).  A small amount of spliced product could be detected by 
RT-PCR (Fig. 3-5C); this RT-PCR product was cloned into pDrive (Qiagen).  
Sequencing of eight clones revealed that 5’SS usage in U2 sequence in the 
context of the reporter gene (Fig. 3-5D) was different from that in the context of 
U2 (Fig. 3-5E).  5’SS usage in the U2-substituted reporter gene correlated 
relatively well with predicted U1 snRNA binding affinity (135), with the upstream-
most 5’SS (AA/GUGUA) used in 4/8 clones and the downstream-most 5’SS 
(UA/GUAUCU) in only 1/8 (cf. 9/13 in the context of trans-splicing to U2).  This 
suggests that, while this region of U2 snRNA sequence can be recognised by U1 
snRNA and participate to a low level in a canonical mRNA splicing reaction when 
placed in the context of an otherwise wild-type reporter gene, it is a suboptimal 
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substrate for splicing.  This rationalises the observation that U2 cannot compete 
effectively with a wild-type 5’SS.  In addition, the different 5’SS preference 
observed between the cis- and trans-splicing reactions indicates that pairing 
between U1 and U2 snRNAs does not determine 5’SS usage in U2 snRNA in 
trans-splicing; the most likely candidate for such a determinant of 5’SS 
preference in trans-splicing is spatial proximity to the BS nucleophile.  The use of 
multiple 5’ splice sites in the trans-splicing reaction is therefore indicative of a 




THE NATURE OF THE TRANS-SPLICING REACTION 
The data presented in this chapter demonstrate the formation of a trans-spliced 
RNA product comprising the 5’ end of U2 and the 3’ exon of an ACT1-CUP1 
reporter with a 5’SS predicted to bind poorly at the spliceosome catalytic centre.  
The possibility of this product being generated by an RT artefact is ruled out by 
its strict dependence on 5’SS mutation.  In strains expressing two distinct U2 
snRNAs, the identity of the U2 portion of the trans-spliced product was observed 
to be dependent on the identity of the U6 expressed by the strain, with the 
potential for helix I formation between U2 and U6 an essential requirement for 
trans-splicing.  Interactions between U2 and U6 are established during the late 
stages of spliceosome assembly, so the requirement for such interactions 
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indicates that U2 snRNA within a functional spliceosome is nucleophilically 
attacked, presumably by the branch site it recruited. 
 
We were able to detect trans-splicing using reporter genes with wild-type 3’ 
splice sites, but not with 3’SS mutants.  In addition, all trans-splicing events 
observed involved the same 3’SS as is used in canonical cis-splicing of the 
reporter gene.  These observations support the hypothesis that the trans-splicing 
reaction is essentially identical to cis-splicing, but with an aberrant first catalytic 
step in which U2, rather than the 5’SS, is attacked; the exon generated by this 
aberrant first step proceeds through the second step in a quasi-normal fashion.  
As we were unable to detect reaction intermediates, the efficiency of this second 
step could not be investigated.  Our inability to detect a branched intermediate 
also renders uncertain the identity of the first-step nucleophile, although the 
inhibition of trans-splicing by mutations at and around BS supports a 2’-5’ 
branching reaction.  A hydrolytic first step analogous to that observed in group II 
introns (136) cannot be ruled out by our data, but in any case the existence of 
such a first step would not substantially affect the interpretation of these data. 
FLEXIBILITY IN THE SPLICEOSOME CATALYTIC CENTRE, AND THE FATE 
OF THE BS-U2 DUPLEX FOR THE FIRST CATALYTIC STEP OF PRE-MRNA 
SPLICING 
Splicing is a multi-step reaction that necessarily involves conformational 
rearrangements as well as complex assembly and disassembly phases; global 
conformational flexibility is clearly required for such a reaction.  In addition to this 
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necessary flexibility, however, splicing is characterised by the need for nucleotide 
precision; this is especially true in S. cerevisiae, an organism with strong splice 
site consensuses in which functionally important alternative splicing has not been 
demonstrated.  Therefore, while both global flexibility throughout the assembly-
reaction-disassembly pathway, and local flexibility at the catalytic centre between 
the two chemical steps are inevitable, tight substrate binding between 
rearrangements is expected.  As noted by Nilsen and co-workers (130), snRNA 
reactivity in spliceosomes is indicative of catalytic centre flexibility.  The reactivity 
of an snRNA region intimately involved in substrate binding during assembly, and 
possibly also catalysis, extends our view of this flexibility to include pairing 
interactions important for splicing fidelity.  The nucleophilic attack of four sites in 
U2 is inconsistent with reactivity within a BS-U2 duplex that has remained intact 
from early spliceosome assembly until the catalytic phase, even in the unlikely 
scenario of a hydrolytic first step.  To rationalise the reactivity of multiple sites in 
U2, it is therefore necessary to invoke at least transient disruption of the 
interaction between BS and U2.  Following this unpairing, three possibilities exist 
between which our data do not allow us to distinguish: the branch site, the 
presumed nucleophile for the first step of the trans-splicing reaction, could attack 
U2 while in a single-stranded state; this seems unlikely, as such circumvention of 
the need for nucleophile activation would be highly surprising in a reaction as 
important and precise as splicing.  A second possibility is that BS may simply re-
pair somewhat inaccurately with U2, and attack from within the resulting re-
formed duplex (Fig. 3-6, iia).  The third possibility is that BS may pair to another 
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RNA strand and attack U2 from within this duplex (Fig. 3-6, iib).  Given the 
similarity between the sequences of the yeast consensus 5’SS and the BS-
binding region of U2, the 5’SS represents an obvious candidate for such a 
partner.  While a complete strand exchange reaction, in which U2 and the 5’SS 
are able to swap positions and roles after assembly, does not appear consistent 
with the wide range of 5’SS mutations that facilitate trans-splicing, partial strand 










Figure 3-6. Possible trans-splicing mechanisms. 
Proposed mechanisms of trans-splicing: (i) RNA-RNA interactions in the fully 
assembled spliceosome, with BS paired to U2. (iia) BS and U2 unpair and re-pair 
potentially inaccurately, with BS nucleophilically attacking U2 from within the 
resulting helix, or (iib) BS and U2 unpair, with new pairing established between 
BS and the 5’SS; BS, bulged from this new helix, attacks U2. (iii) 5’SS-U6 and 
BS-U2 pairing both having been disrupted, the ‘U2 5’ exon’ generated in step ii 
attacks the reporter gene 3’SS, generating (iv) a branched product comprising 
the 3’ end of U2 appended to the 5’ exon and intron of the reporter gene, and a 
linear product comprising the 5’ end of U2 appended to the reporter 3’ exon. 
THE FATE OF THE BS-U2 DUPLEX FOR THE SECOND CATALYTIC STEP 
OF PRE-MRNA SPLICING 
The persistence after the first step of splicing of the entire U2-BS helix, 
established during the early stages of spliceosome assembly, is not inconsistent 
with any previously published data.  Our data, however, clearly suggest that the 
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persistence of this helix is at least not required for the second step of splicing.  
As indicated in figures 3-1A and 3-5E, the predominant 5’SS used in U2 lies in 
the middle of this helix, which must therefore be at least partially disrupted in 
order for the ‘U2 5’ exon’ to be free to attack the 3’SS during the second step.  
Given that the structural consequences of the absence of a helix normally 
present in the second step conformation of the spliceosome would likely cause a 
severe, if not terminal, second step block, and that the second step of the trans-
splicing reaction appears to be analogous to the second step of canonical cis-
splicing, we hypothesise that the U2-BS helix does not normally persist during 
the second step, and that the removal of the lariat intermediate, generated in the 
first step, from the catalytic centre prior to the second step may be linked to the 
unpairing of its BS portion from U2 snRNA as well as the disruption of the 5’SS-
U6 snRNA interaction (44).  Although these conclusions are based on an 
infrequent trans-splicing reaction, the capacity of the spliceosome to support 
such a reaction has important implications for physiologically relevant pre-mRNA 
splicing.  We note that such trans-spliced products may have been identified in 
high-throughput RNA sequencing experiments in both yeast and higher 
eukaryotes, but that hybrid RNAs containing snRNA sequence would likely be 
filtered out by existing algorithms.  Identification of further such products could 
provide valuable mechanistic information, and as such may be worth the 




CHAPTER 4. INVESTIGATION OF BRANCH NUCLEOPHILE 




The BS-U2 duplex has been proposed to play a role in nucleophile specification 
and activation at the stage of first step splicing catalysis, in which the 2’ hydroxyl 
group of a conserved adenosine at the BS nucleophilically attacks the 5’SS.  The 
conserved 5’-GΨAGUA-3’ motif in U2 allows the second A in the conserved 5’-
UACUAAC-3’ branch site (the canonical BS nucleophile is highlighted) to bulge 
from the helix (Fig. 4-1).  Substitution of the first adenosine in the AA pair with 
arabinosyl adenosine favours bulging of this unreactive nucleotide rather than the 
adjacent and normally favoured adenosine, and inhibits first step catalysis in 
HeLa extract (137).  In addition, NMR studies on model duplexes suggest that 
pseudouridylation at position 35 in U2 snRNA favours the conformation of the 
duplex in which the BS-A is extruded from, rather than intercalated into, the helix 
(138).  Deletion of Pus7, the pseudouridine synthase responsible for this 
modification in S. cerevisiae, confers sickness, presumably due to a splicing 
defect, on cells with mildly mutated U2 snRNA (139).  Finally, abrogation of an 
analogous bulged adenosine in domain 6 of a group II self-splicing intron virtually 
abolishes first step catalysis by branching, with little to no negative impact on the 
hydrolytic first step pathway (140).  Together, these studies indirectly suggest 
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that bulging of the BS nucleophile via interaction with U2 is important for 
branching catalysis by the spliceosome. 
 
Figure 4-1. Schematic of RNA-RNA interactions during the first step of 
splicing.   
The pre-mRNA is shown in black, with the branch site (BS) adenosine 
highlighted in blue: U2 snRNA is shown in red, U5 in grey and U6 in green.  U2 
positions A31 and G32 are shown in lowercase throughout figures in this chapter 
for positional reference. 
 
The ability of the higher eukaryotic spliceosome to catalyse 2’-5’ branch 
formation using either adenosine in -UAAC as a nucleophile (137), and poor 
conservation of both the BS and 5’SS in higher eukaryotes (2) are indicative of 
flexibility with respect to the selection and activation of nucleophile and 
electrophile.  Yeast, by contrast, have strong splice site consensus sequences 
and appear to have strict positional requirements for the BS nucleophile: 
mutation of the BS-A to a pyrimidine, instead of activating the upstream 
adenosine, results in inefficient splicing from the mutated nucleotide (141). 
However, the observation, described in chapter 3, that multiple sites within the 
BS-binding region of U2 snRNA can be used in trans as 5’ splice sites for both 
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steps of splicing in vivo suggests a fairly large degree of active site flexibility, and 
implies that the BS-U2 interaction might be more dynamic and/or transient than 
previously thought.  
 
The data in this chapter demonstrate the importance of nucleophile bulging for 
splicing catalysis.  From the systematic movement of a bulge motif through the 
BS-U2 duplex in vivo in S. cerevisiae, we conclude that adenosines bulged from 
at least three positions within the BS-U2 duplex are competent to act as the first-
step nucleophile.  Mutations in the BS-binding region of U2 have unpredictable 
effects on splicing and cell growth.  An orthogonal system is therefore desirable 
in which a constant second copy U2 snRNA, capable of splicing a reporter 
transcript but not of interacting with endogenous introns, can be used for the in 
vivo investigation of nucleophile positioning.  We report the development and 
characterisation of such a BS-U2 system.  We show unambiguously that three 
bulge positions can participate in first step catalysis, and confirm the importance 
of nucleotide identity at the branch site.  We also show that the branch site and 
5’SS are positioned independently for first step catalysis, and that the favoured 
position of the branch nucleophile is dependent on distance from the U2 




BULGING IS REQUIRED FOR SPLICING, BUT THE POSITION OF THE 
BULGE WITHIN THE BS-U2 DUPLEX IS FLEXIBLE 
The trans-splicing reaction described in chapter 3 suggested global flexibility in 
the S. cerevisiae spliceosome: further evidence of flexibility came from the result 
of a mutagenesis screen for U2-based suppressors of splicing defects due to 
mutation of the branch site nucleotide.  Because U2 is essential and sensitive to 
mutation in its BS-binding region, this mutagenesis screen and all subsequent 
experiments involving mutant U2 snRNAs were performed using a strain carrying 
both a wild-type copy of U2 and a second gene encoding the mutant.  One U2 
allele capable of suppressing the splicing defect of BS-C (5’-UACUACC-3’) was 
identified as Ψ35G (5’-GGAGUA-3’).  Other mutations at this position failed to 
suppress BS-C (Fig. 4-2A&B), and other BS mutations could be suppressed by 
analogous mutations of position 35 to the Watson-Crick base-pairing partner of 
the mutated BS nucleotide (data not shown).  This suggested that the splicing 
defect due to BS mutation was overcome via bulging and activation of the 
preceding adenosine – a conclusion confirmed by primer extension analysed at 
single nucleotide resolution (Fig. 4-2B, middle panel).  The ACT1-CUP1 reporter 
encodes a metallothionein whose expression correlates over a large dynamic 
range with resistance to copper in the growth medium (132).  All primer extension 
data in this and subsequent experiments were confirmed by copper growth 
assays (Fig. 4-2B, lower panel, and data not shown); this verifies that mRNA is 









Figure 4-2. Bulging of the branch site nucleophile is required for splicing in 
S. cerevisiae: the position of the bulge within the BS-U2 duplex is flexible. 
 (A) Schematic of the BS-U2 pairing regions of the wt and BS-C mutant reporters, 
and wt and Ψ35G U2 snRNAs used in [B].  (B) An intron BS-C mutation can be 
suppressed by U2 Ψ35G but not by other mutations at this position: upper panel 
– splicing efficiency monitored by primer extension with a 3’ exon primer on S. 
cerevisiae total RNA from strains carrying the indicated U2 snRNA and reporter 
constructs; middle panel – primer extension with an intronic primer immediately 
upstream of BS indicates that the Ψ35G suppressor promotes the use of a non-
canonical adenosine as the branch nucleophile; lower panel – copper growth 
assay to verify that the mRNA observed in the upper panel is functional.  (C) 
Schematic of reporter and U2 constructs used in [D].  (D) Primer extensions with 
3’ exon (upper panel) and BS-proximal intronic (lower panel) primers on total 
RNA from the indicated strains indicate that branch nucleotide bulging is required 
for splicing, but the position of the bulge within the BS-U2 duplex is not fixed.  (E) 
Schematic of reporter and U2 constructs used in [F].  (F) In vitro splicing (upper 
panel) and spliceosome assembly (lower panel) of the S. cerevisiae UBC4 intron 
carrying the indicated BS mutations, as assayed by denaturing and native PAGE, 
respectively.  BS-C and ΔBS-A mutations allow reduced spliceosome assembly 











The use of a positionally non-canonical BS nucleotide does not normally occur in 
S. cerevisiae; our data suggested both that bulging of the BS was likely required 
for catalysis as well as assembly, and that S. cerevisiae could be induced to 
display the same flexibility as higher eukaryotes with respect to branch 
nucleophile positioning.  We introduced pairs of mutations into the BS and a 
second copy U2 snRNA such that the bulge was flattened by insertion or deletion 
of a nucleotide in the BS sequence, and restored by corresponding deletion or 
insertion in the second copy U2 (Fig. 4-2C).  As expected for an essential bulge, 
introns that generated flat duplexes failed to support splicing (Fig. 4-2D, lanes 
2&4), and restoration of the bulge via either insertion or deletion in U2 snRNA 
restored splicing activity, albeit with reduced efficiency relative to the wt BS-U2 
pair (Fig. 4-2D, lanes 3, 5&6).  To distinguish between assembly and catalytic 
phases of splicing, we assayed spliceosome assembly and splicing progression 
in vitro using S. cerevisiae whole cell extract and the efficiently spliced UBC4 
transcript (John Abelson, personal communication) carrying a variety of 
mutations at and around the BS.  Analysis of splicing reactions in native and 
denaturing polyacrylamide gels indicated that deletion of the branch nucleophile 
to produce a flat BS-U2 duplex allowed spliceosome assembly at a level 
comparable to that shown by an intron carrying a BS-C mutation: neither of these 
mutant introns, however, showed detectable splicing catalysis, in contrast to the 
efficient splicing of the wt UBC4 intron (Fig. 4-2E&F).  As expected, an intron with 
a severely mutated BS region failed to elicit detectable spliceosome assembly 
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(Fig. 4-2E&F).  These results indicate that both the presence and the nature of 
the bulged nucleophile are important for splicing catalysis as well as assembly. 
 
High-resolution primer extension of in vivo splicing indicated that the expected 
branch nucleophile was used for each BS-U2 pair that showed detectable 
splicing (Fig. 4-2D, lower panel – the background band at the wt position is due 
to extension on endogenous actin), indicating that changing the length of the BS-
U2 duplex, and correspondingly moving the bulged adenosine towards or away 
from its helix III-proximal end (Fig. 4-1, 4-2B&C), does not abolish the ability of 
this adenosine to act as the nucleophile for the first step of splicing in this 
context. 
SYSTEMATIC MOVEMENT OF A CAC MOTIF THROUGH THE BS-U2 
DUPLEX INDICATES THAT THREE DUPLEX BULGE POSITIONS CAN 
PARTICIPATE IN CATALYSIS 
To further investigate the apparent flexibility of nucleophile location within the BS-
U2 duplex, we generated a series of BS-U2 pairs in which a 5’-CAC-3’ motif was 
systematically placed at all positions in the BS-U2 duplex opposite a 5’-GG-3’ 
motif in the second copy U2 to produce a bulge whose nature remained constant 
while its position within the helix was varied (Fig. 4-3A).  Primer extension 
analysis of total RNA isolated from strains carrying these BS-U2 pairs indicated 
that a bulged adenosine placed at any of three positions in the duplex could 
participate in first step splicing catalysis (Fig. 4-3B).  If the canonical BS position 
is defined as 0, these positions are -1 (immediately upstream of the BS in the 
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pre-mRNA), 0 and +1 (immediately downstream) (Fig. 4-3B, lanes 4-7).  Bulged 
adenosines further up- or downstream showed no reactivity (Fig. 4-3B, lanes 2-3 
and data not shown). 
 
 
Figure 4-3. Systematic variation of bulge position indicates that at least 
three positions within the BS-U2 duplex are competent for first step 
catalysis. 
(A) Schematic of reporter and U2 constructs used in [B].  (B) Primer extension 
with a 3’ exon primer indicates that the -1, 0 and +1 BS bulge positions allow 
splicing catalysis.  In this and subsequent figures, a band resulting from 
degradation of pre-mRNA is marked by an asterisk. 
 
GROSSLY SUBSTITUTED BS-U2 PAIRS FUNCTION IN SPLICING: 
DEVELOPMENT OF AN ORTHOGONAL BS-U2 SYSTEM 
The BS-binding region of U2 snRNA is universally conserved in crown group 
eukaryotes, although U2s from highly divergent eukaryotes (e.g. kinetoplastids) 
have different sequences (Fig. 4-4A): minor changes both in this sequence and 
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throughout the highly conserved 5’ end of U2 are generally lethal as a sole copy 
and can impair cell growth as a second copy (124, 142).  These negative effects, 
together with potentially variable expression levels of mutant U2s, preclude 
direct, quantitative comparison of branching efficiency from different BS-U2 
duplex positions, as a different U2 is required for each reporter gene.  We sought 
to generate BS-U2 pairs to allow the fair comparison of different branch positions 
and nucleophiles within the context of a constant U2 sequence.  These second 
copy U2 snRNAs were designed to be orthogonal to wt U2 – that is, they would 
interact with the reporter transcript but not with endogenous introns, while the 





Figure 4-4. A wide variety of grossly substituted BS-U2 pairs are functional 
for splicing, and are orthogonal to the endogenous splicing machinery. 
(A) Alignment of U2 snRNA sequences from (S. cerevisiae) positions 26 to 49 
from diverse organisms: the BS-binding region, highlighted in red, is 100% 
conserved in crown group eukaryotes.  (B) Schematic of wt and grossly 
substituted reporter and U2 constructs used in [C].  (C) Primer extension with a 3’ 
exon primer indicates that grossly substituted branch sites allow splicing catalysis 
in the presence of their cognate U2 (c) (numbers refer to [B]), but not wt U2 (w).  
(D) Primer extension with ddTTP replacing dTTP to assay the expression of U2 
snRNAs with wild-type and GC-substituted (orthogonal) BS-binding regions.  (E) 
Primer extension on total RNA from the indicated strains with a BS-proximal 
intronic primer (middle panel) and copper growth (lower panel) indicate that the 
expected branch nucleotide is used and that the mRNA resulting from splicing is 
functional, for representative grossly substituted BS-U2 duplex 2 from [B] 
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We generated several U2 snRNAs in which the entire BS-binding region was 
substituted, typically with only C and G nucleotides, together with corresponding 
reporter transcripts for each (a selection is shown schematically in Fig. 4-4B).  
The U2s that we tested included ones in which all nucleotides were mutated to C 
or G, with purine/pyrimidine identity preserved (Fig. 4-4B, #2) or transverted (#8) 
at each position, and one in which the sequences of the BS and U2 were 
effectively swapped such that the mutant U2 sequence corresponded to that of a 
flattened branch site and the reporter to that of a bulged U2 snRNA (Fig. 4-4B, 
#7).  Virtually all grossly substituted BS-U2 pairs could participate in both steps of 
splicing, although the efficiency of the first step was variable (Fig. 4-4C, lanes 2-
8(c), and data not shown).  As expected, the substituted reporter failed to splice 
in the absence of its corresponding U2 (Fig. 4-4C, lanes 2-8(w), and data not 
shown).  For all BS-U2 pairs, we verified by high-resolution primer extension that 
the anticipated branch nucleophile was used, and confirmed by copper growth 
(representative data for BS-U2 pair #2 are shown in Fig. 4-4E; data not shown for 
other constructs).  Thus, despite its extreme conservation, the BS-U2 duplex is 
remarkably tolerant to substitution. 
 
Using a primer extension assay in which the primer abutted the BS-binding 
sequence in U2, and ddTTP replaced dTTP, we were able to distinguish 
between, and thus assay the levels of, wt and most orthogonal U2 snRNAs (Fig. 
4-4D); we presume these to reflect the level of U2 snRNP, as we expect 
unassembled U2 snRNA to be rapidly degraded.  Orthogonal U2 expression, 
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while variable, shows no correlation with splicing efficiency (Fig. 4-4C&D, 
quantitation in Fig. 4-5C), suggesting that U2 snRNA expression does not 
normally limit splicing in our system.  The first step defect indicated by the 
accumulation of pre-mRNA (Fig. 4-4C) may instead reflect suboptimal packing of 
substituted BS-U2 duplexes with other spliceosome components.  This is 






Figure 4-5. Further characterisation of the orthogonal BS-U2 system. 
(A) Constructs used in this figure: sequences and numbering as in Fig. 4-4.  (B) 
Total U2 snRNA expression (wild-type and orthogonal U2 snRNAs) in each 
strain: quantitation refers to Fig. 4-4D.  U2 expression was corrected for unequal 
loading using the internal U6 control, and normalised to the expression of wild-
type U2 in the strain carrying no mutant U2 allele.  (C) The efficiency of 
orthogonal splicing does not correlate with the expression of the orthogonal U2 
snRNA: quantitation refers to Fig. 4-4C&D.  (D) Growth curves of strains carrying 
the indicated second-copy U2 snRNA. (E) The variable growth rate of strains 
carrying orthogonal U2 snRNAs is not related to reduced expression of wild-type 
U2.  Relative growth rates were calculated as the gradient of the linear region 
from O.D. 0.2-0.4 in [D] after log transformation, represent the mean value from 
the three curves, and were normalised relative to the strain carrying two wild-type 
copies of U2.  Error bars represent ±1 standard deviation.  U2 expression levels 
refer to Fig. 4-4D. 
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Strains carrying certain mutant second copy U2 alleles exhibited slow growth 
(Fig. 4-5D&E).  We do not know the basis of this growth defect, as it does not 
correlate with reduced or excessive expression of either the wt or the mutant 
copy of U2 snRNA (Fig. 4-5B&E and data not shown).  We also do not believe 
that deleterious generation of new, orthogonal BS-containing introns contributes 
substantially to the observed growth defect: although we identified candidate pre-
mRNAs in which new introns may be generated by our orthogonal U2s, we were 
unable to detect the products of such new splicing events by RT-PCR for either 
of two strongly predicted introns tested (data not shown). 
ESTABLISHMENT OF NUCLEOPHILE REQUIREMENTS FOR THE FIRST 
STEP OF SPLICING 
The orthogonal BS-U2 system minimises both inter-strain growth differences and 
potential interaction between the mutant BS reporter and wt U2 snRNA, allowing 
systematic investigation of the effect of branch nucleotide identity, context and 
positioning in a constant U2 background.  Our previous analysis had suggested 
that bulges from at least three positions within the BS-U2 duplex were competent 
for first step catalysis.  Using reporters in which all BS flanking sequence was 
mutated to G/C with purine/pyrimidine identity either maintained or transverted 
(UACUAACA to CGCCGACG or GCGGCAGC, respectively – the zero position 
branch nucleotide is highlighted), we placed a bulged adenosine at all positions 
from -4 to +1 (Fig. 4-6A&C) and assayed splicing by primer extension and copper 
growth (Fig. 4-6B&D and data not shown).  We observed relatively efficient 
branching from the 0 or -1 positions in both constructs (Fig. 4-6B&D), and 
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additionally from the +1 position in the transverted duplex, but not from bulged 
nucleotides further upstream than the -1 position (Fig. 4-6D and data not shown).  
This confirms the positional flexibility of branching in the context of a constant U2 
snRNA background – bulges at the -1 and +1 positions are expected to be 
separated by around 8 Å and 90˚ (143). 
 
 
Figure 4-6. Confirming the positional flexibility of the branch nucleophile. 
(A) Schematic of reporter and U2 constructs used in [B].  (B) Primer extension on 
total RNA from the indicated strains with 3’ exon (panel i), BS-proximal intronic 
(panel ii), and 5’SS-proximal intronic (panel iii) primers indicates that two bulge 
positions in this duplex are catalytically competent, that the expected branch 
nucleotide is used in each case, and that the location of the branch nucleotide in 
the BS-U2 duplex does not affect the position of 5’SS cleavage.  Panel iv, 
quantitation of the 3’ exon primer extension in (i).  (C) Schematic of reporter and 
U2 constructs used in [D].  (D) Primer extension on total RNA from the indicated 
strains primers as in [B] indicates that three bulge positions in this duplex are 
catalytically competent, and, as in [B], that the branch nucleophile can be moved 
without changing the position of 5’SS cleavage 
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We believe the disparity between the two constructs to be related to base pair 
identity flanking the bulge.  Base pairing at both flanking positions strongly 
favours splicing (Fig. 4-7A), and nucleotide identity within the pair impacts 
splicing efficiency (Fig. 4-7B): consistent with flanking base pair identity 
underlying the observed difference in the use of the +1 position in the pseudo 
wild-type CG (CGCCGCAG) and transverted GC (GCGGCGAC) duplexes (both 
sequences shown with a highlighted +1 adenosine), splicing is more efficient for 
branch nucleotides preceded by a purine and followed by a pyrimidine than the 
converse (Fig. 4-7B).  Thus, one would expect the +1 position to be relatively 
favoured in the context of the transverted GC duplex, and relatively disfavoured 
in the pseudo wild-type CG context.  Moving the branch site A in the context of 
some orthogonal BS-U2 duplexes imposes a strong block on the second step of 
splicing (Fig. 4-7B and data not shown): we do not know the mechanistic basis 
for this defect, but this is discussed more fully in chapter 5, in the context of 
branch site interactions during the second step of splicing. 
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Figure 4-7. Base pairs flanking the branch are required for efficient 
splicing: base pair identity impacts splicing efficiency. 
(A, B) Graphs summarising the copper growth of strains carrying the indicated 
reporter-U2 pairs.  The sequence of the BS used in this analysis is CGCCNANG. 
 
Splicing, both in yeast (134) and in higher eukaryotes (144), is most efficient with 
an adenosine branch nucleophile: guanosine is mildly suboptimal and either 
pyrimidine nucleotide even more so.  The effects of BS mutation, however, have 
been studied in a small number of genes, and in an otherwise wt BS-U2 context: 
alternative pairings for such duplexes can be envisaged in which an ‘incorrect’ 
nucleotide is bulged – i.e. the observed splicing defect may arise due to bulging 
nucleotides suboptimal in terms of identity or of position.  We produced duplexes 
with only one pairing register, and a BS nucleotide flanked by a pair of either 
guanosine or cytosine nucleotides (Fig. 4-8A), to facilitate the predictable bulging 
of A/C/U or A/G/U, respectively.  The splicing profile of these reporters mirrored 
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that of BS mutants in a wt context, with guanosine supporting a fairly efficient first 
step and pyrimidines showing little to no branching (Fig. 4-8B). These data 
support an inherent preference for adenosine at the branch position, as 
previously suggested by work showing recognition of multiple groups on the 
adenosine nucleotide during spliceosome assembly and catalysis ADDIN 
BEC(145, 145), the branch site specificity of group II introns (146), and an 
apparently intrinsic preference for adenosine as the nucleophile in 2’-5’ branch 
formation in some other contexts (147).  A fuller treatment is given to the issue of 
the role of adenosine in RNA branching reactions in Chapter 5. 
 
 
Figure 4-8. Confirming the preferred identity of the branch nucleophile. 
(A) Schematic of reporter and U2 constructs used in [F].  (B) Primer extension 
using a 3’ exon primer indicates an intrinsic nucleotide preference at the branch 
site, with A>G>>C~U.  (C) Schematic of reporter and U2 constructs used in [H].  
(D) Primer extension indicates that branching occurs from the upstream-most 




A remaining question was the behaviour of branch sites with multiple consecutive 
bulged nucleotides.  We constructed BS-U2 pairs containing one, two or three 
consecutive unpaired adenosines (Fig. 4-8C).  The presence of additional 
unpaired adenosines impaired splicing of the reporter (Fig. 4-8D, upper panel), 
presumably due to the lack of base pairing downstream of the branch site 
adenosine (cf. Fig. 4-7).  Splicing did, however, occur to detectable levels and 
high-resolution primer extension indicated that the upstream-most adenosine 
was invariably used as the branch nucleophile (Fig. 4-8D).  These results recall 
data regarding branch site selection in the minor spliceosome (148), and suggest 
a model whereby the most upstream unpaired adenosine in the BS-U2 or BS-
U12 duplex is specified as the branch nucleophile. 
GROSSLY SUBSTITUTED BS-U2 DUPLEXES PREDOMINANTLY IMPAIR 
SPLICEOSOME ASSEMBLY: INAPPROPRIATELY BULGED NUCLEOTIDES 
LIMIT CATALYSIS 
Although virtually all grossly substituted BS-U2 duplexes supported splicing, first-
step efficiency was invariably diminished relative to that observed for a wt BS-U2 
pair (Fig. 4-4C).  Spliceosome assembly precedes branching catalysis, and the 
observed accumulation of pre-mRNA could be due to a defect in either or both of 
these steps.  The BS-U2 duplex, as a highly conserved element containing a 
first-step substrate, likely forms several tertiary interactions in the spliceosome 
core; although our mutant pairs are stably base-paired, we expected that they 
might be deficient in some such interactions. 
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To clarify the nature of the defect shown by our constructs, we investigated their 
splicing in the context of mutant alleles of the spliceosomal ATPases Prp5 and 
Prp16.  Prp5 has been proposed to monitor the stability of BS-U2 interaction 
during spliceosome assembly via kinetic competition between its ATPase activity 
and BS-U2 pairing – failure to establish stable interaction prior to ATP hydrolysis 
by Prp5 leads to pre-mRNA discard (36).  Mutant prp5 alleles, by relaxing the 
stability requirement for the nascent complex, thus facilitate spliceosome 
assembly on introns with suboptimal BS-U2 pairing and presumably also those in 
which a stable duplex is imperfectly packed.  Prp16 enhances splicing fidelity by 
acting in competition with splicing catalysis – failure to complete first step 
catalysis prior to ATP hydrolysis by Prp16 leads to pre-mRNA discard (51).  A 
suboptimally packed BS-U2 duplex could inhibit first step catalysis by globally 
destabilising the first step conformation of the spliceosome. 
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Figure 4-9. Grossly substituted BS-U2 duplexes predominantly impair 
spliceosome assembly: inappropriately bulged nucleotides predominantly 
impair splicing catalysis. 
(A) Schematic of the BS-U2 duplex used in this figure, with the positions of 
bulged adenosines indicated.  (B) Primer extension using a 3’ exon primer on 
total RNA from strains carrying reporters with adenosines bulged from the 
indicated positions in a grossly substituted BS-U2 duplex and either wt or mutant 
Prp5.  (C) Graph indicating the fold change in branching efficiency [calculated as 
(M+LI)/(P+M+LI)] at the -1 and 0 bulge positions as a result of Prp5 mutation.  (D, 
E) As [B, C], but comparing wt and mutant Prp16.  
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For each ATPase we assayed the splicing efficiency, in a wt and a mutant strain, 
of substrates with a CGCCGAC branch site with an adenosine at either the -1, 0 
(highlighted here), or +1 positions (Fig. 4-9A).  The prp5 N399D allele (36) 
stimulated splicing from the 0 position ~1.5-fold, yet had little effect on the 
splicing of a reporter with a -1 position branch adenosine (Fig. 4-9B&C).  By 
contrast, the prp16-101 allele (51) stimulated the splicing of the -1 position 
reporter 1.8-fold but had little effect on the 0 position reporter (Fig. 4-9D&E).  
Taken together, these observations suggest distinct limiting steps in the splicing 
pathway for the -1 and 0 position reporters.  In this context, spliceosome 
assembly is impaired by duplex substitution: the mutant prp5 allele suppresses 
this assembly defect.  In a substrate with an optimally positioned 0 position 
bulge, enhanced assembly leads to enhanced splicing.  With the nucleophile 
bulged from the -1 position, however, increased assembly does little to stimulate 
splicing because the overall efficiency of the reaction is limited by first step 
catalysis: in this case, the slowed exit from the first step conformation afforded by 
prp16 mutation strongly stimulates branching.  These results not only define the 
limiting steps in the splicing pathway for orthogonal BS-U2 pairs, but also 
indicate that the position of the bulged nucleophile within the BS-U2 duplex is 
important for first step catalysis by the spliceosome. 
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THE PREFERRED NUCLEOPHILE POSITION DEPENDS ON DISTANCE 
FROM THE U2 PORTION OF U2/U6 HELIX IA, AND DOES NOT DETERMINE 
5’SS SELECTION 
The analysis described above demonstrates the flexibility of branch site 
activation within a constantly positioned BS-U2 duplex, without addressing how 
movement of the duplex itself may affect branch site selection.  U2 snRNA is 
involved in several intra- and intermolecular structures within the catalytic 
spliceosome (2).  We therefore sought, again using a constant BS sequence 
from which an adenosine could be bulged at multiple positions, to investigate the 
impact on preferred bulge position of changing the distance between BS-U2 and 
these spliceosomal structures.  Because our second copy U2s do not interfere 
with the splicing of endogenous introns, we were relatively unconstrained in our 
choice of mutations, and made a large number of insertion and deletion mutants 
throughout the 5’ end of U2, including into either the stem or loop of the 5’ stem 
loop, up- and downstream of helix I, and upstream of helix III (Fig. 4-10).  Several 
of these mutant U2s failed to show stable expression, presumably due to an 
inability to assemble into snRNPs (data not shown); all expressed U2s with 
insertions/deletions anywhere upstream of helix I showed at worst a mild splicing 
defect with no impact on branch nucleophile selection (data not shown).  Of most 
interest were insertions predicted to alter the distance between helices Ia & III 
and the BS-U2 duplex, which lies between the U2 components of each (61, 149), 
as this network of interactions may help to juxtapose key catalytic components 
and splicing substrates. 
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Figure 4-10. Insertions and deletions in the conserved 5’ end of U2 tested 
for effects on branch nucleophile selection. 
Arrows indicate the locations of insertions/deletions.  Deleted nucleotides are 
highlighted with blue trim. 
 
An all-CG branch site with the (0 position branch) sequence CGCCGAC shows 
branching from the -1 and 0 positions in the presence of its cognate U2 snRNA 
(Fig. 4-11A).  Insertion of two nucleotides into U2 upstream of helix III, with 
accompanying deletion of two nucleotides downstream of helix Ia, predicted to 
shift the BS-U2 duplex towards helix Ia and away from -III, altered this splicing 
profile such that the -2 position was now highly active for branching and the 0 
and -1 positions less favoured than in the original context (Fig. 4-11B).  An 
analogous 1-nt insertion/deletion pair also shifted the observed branching 
preference towards upstream bulges (data not shown).  Conversely, deleting one 
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nucleotide upstream of helix III and inserting one downstream of helix Ia, 
predicted to shift BS-U2 away from helix Ia and towards -III, disfavoured the use 
of the -1 position while maintaining robust use of the 0 position BS (Fig. 4-11C).  
Collectively, these data suggest that branch position relative to either or both of 
these helices impacts the bulge positions within the BS-U2 duplex that are 








Figure 4-11. Distance from the U2 component of U2/U6 helix Ia partially 
determines the preferred position of the BS nucleophile within the BS-U2 
duplex. 
For each panel: (i) Simplified schematic of the spliceosome catalytic centre with 
helices Ia and III indicated; BS adenosines in blue are sized proportionally to 
their ability to participate in splicing catalysis based on quantitation (v) of the 3’ 
exon primer extension in (ii).  Branch site and 5’SS use are assayed by primer 
extension in (iii) and (iv), respectively: the position of the branch nucleotide both 
within the BS-U2 duplex and relative to the U2 component of helix Ia does not 
impact the position of 5’SS cleavage.  All panels use an all-CG BS-U2 duplex, 
indicated below the figure, in which purine-pyrimidine identity is maintained at 
each position relative to wild-type.  (A) Profile of -3 to +1 bulged reporters with 
CG-substituted but otherwise wt U2.  (B) Deletion of two nucleotides in U2 
downstream of helix Ia, and insertion of two nucleotides upstream of helix III, 
predicted to move the BS-U2 duplex towards helix Ia and away from helix III, 
activates upstream bulge positions for catalysis.  (C) Insertion of one nucleotide 
in U2 downstream of helix Ia, and deletion of one nucleotide upstream of helix III, 
predicted to move the BS-U2 duplex away from helix Ia and away towards helix 
III, represses the use of upstream bulge positions for catalysis.  (D) Deletion of 
two nucleotides in U2 downstream of helix Ia recapitulates the effect seen in [B], 
activating upstream bulge positions for catalysis.  (E) Deletion of one nucleotide 
in U2 upstream of helix III does not strongly impact the catalytic potential of 









To investigate the relative importance of BS distance from helices Ia and III, we 
produced constructs with single-site deletions either downstream of helix Ia or 
upstream of helix III.  Deletion of two nucleotides downstream of helix Ia again 
activated branching from the -2 position (Fig. 4-11D), recapitulating the result of 
such a deletion in the context of an accompanying helix III-proximal insertion (cf. 
Fig. 4-11B&D).  By contrast, a 1-nt deletion upstream of helix III produced a 
splicing profile very similar to that of the original orthogonal U2 (cf. Fig. 4-
11E&A).  These data show that the distance from the branch nucleophile to the 
U2 component of helix Ia is an important determinant of nucleophile specification 
for catalysis.  We note that this distance requirement may be relative either to 
helix Ia or to a rigid higher-order structure containing this helix.  Despite the 
activation of upstream bulge positions for catalysis by helix Ia-proximal deletion 
in U2, branching remains most efficient from the zero position (Fig. 4-11B&E).  
We hypothesise that this position within the duplex remains the optimal one, and 
that the distance between the bulge and helix Ia is an (at least partially) 
independent factor in nucleophile determination. 
 
To confirm the above analysis, we recapitulated the results in the context of the 
transverted GC duplex.  Again, reducing the distance between the BS-U2 duplex 
and helix Ia led to relative activation of upstream bulge positions for first step 
splicing catalysis (Fig. 4-12A&B).  We note that the distribution of upstream 
branch use differs between the two constructs; as previously discussed, we 
believe that flanking base pair identity underlies this observed difference. 
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Figure 4-12. Confirmation of the effect of distance between nucleophile and 
helix Ia in the context of a transverted GC duplex. 
(A, B) (i) Simplified schematic as in Fig. 4-11, with BS adenosines sized 
according to quantitation (iii) of the 3’ exon primer extension in (ii).  An all-CG 
BS-U2 duplex, indicated below panel (iii), in which purine-pyrimidine identity is 
reversed at each position, is used.  Relative to the U2 used in [A] (also shown in 
Fig. 4-6D), the U2 in [B] carries a deletion downstream of helix Ia, predicted to 
activate bulge positions upstream of 0. 
 
Although either or both of the branch nucleophile and the entire duplex from 
which it was bulged were moved in the above analysis (Fig. 4-6, 4-11&4-12), and 
high-resolution primer extension confirmed the potential to use various different 
branch sites, the 5’SS remained unchanged and no activation of cryptic sites was 
observed in any of this work (Fig. 4-6B&D, lower panel, and panel iv of Fig. 4-
11).  If 5’SS positioning were dependent on BS positioning, or if the structures 
that contained the 5’SS and BS, rather than the reactive groups themselves, 
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were positioned relative to one another, movement of the branch site nucleophile 
and/or BS-U2 duplex would be expected to result in an analogous movement of 
the 5’SS.  Therefore, the observation that moving the BS or the duplex containing 
it fails to impact 5’SS selection suggests that the position of the BS nucleophile 
does not determine the position of the 5’SS electrophile for the first step of pre-
mRNA splicing. 
DISCUSSION 
In vivo systems incontrovertibly provide the most valid environment for the study 
of biological processes.  Unfortunately, however, in vivo mutational analyses are 
restricted by a requirement for cell viability.  Orthogonal systems, in which a 
nonessential second copy enzyme exclusively targets its cognate substrate 
(which is in turn not a substrate for the wild-type cellular enzyme) offer the 
possibility of combining the power of the in vivo setting with the mutational 
freedom of in vitro analysis.  Essential, highly conserved base pairing 
interactions, when not complicated by competing pairings, are ideally suited to 
the generation of such systems: an approach based on the replacement of the 
Shine-Dalgarno interaction, has been used to produce orthogonal ribosomes in 
E. coli (150).  Here we describe a system for the study of pre-mRNA splicing, 
based on the analogously conserved interaction between the intron branch site 
and its cognate sequence in U2 snRNA.  We use a variety of BS-U2 pairs to 
investigate the flexibility of nucleophile selection for the first step of splicing in 
yeast.  Our results establish conclusively that bulging of the nucleophile is 
required for first step catalysis, confirm the importance of branch nucleophile 
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identity and location, and suggest a model whereby the first unpaired nucleotide 
in the BS-U2 duplex is specified as the nucleophile.  Additionally, our data 
indicate a high degree of flexibility in the active site of the yeast spliceosome, and 
strongly argue that 5’SS and branch site specification within the catalytic centre 
are independent.  Finally, they extend the evidence for similarity between the 
spliceosome and group II self-splicing introns to include a common mechanism of 
first step nucleophile specification and positioning. 
FLEXIBILITY OF FIRST STEP NUCLEOPHILE SPECIFICATION 
The yeast spliceosome has stringent substrate requirements for assembly and 
catalysis; we show that nucleophile bulging is required for splicing catalysis but 
that, outside of this constraint, there is flexibility with respect to branch 
nucleophile selection and positioning.   
 
No single feature of the branch site aside from nucleophile identity appears to 
exert a strongly dominant effect on the efficiency of splicing; instead, positive and 
negative influences accumulate to produce intermediate phenotypes.  This is 
clear from the distribution of branch site use from all-CG BS-U2 duplexes in 
which purine-pyrimidine identity is maintained (BS 0 sequence CGCCGAC – 
pseudo wild-type) or reversed (BS 0 sequence GCGGCAG - transverted) relative 
to wild-type (UACUAAC) at each position.  In the context of an otherwise wild-
type U2 (Fig. 4-12A), the efficiencies of branching from the -1, 0 and +1 positions 
in the reporter are reasonably similar.  Although the 0 bulge is positionally 
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optimal within the duplex and relative to helix Ia, identity of flanking base pairs is 
not (Fig. 4-7B).  Bulges at ±1 are suboptimal for branching, and -1 appears to be 
less disfavoured than +1 (see for example Fig. 4-6B), but in the transverted 
duplex this effect is mitigated by the presence of flanking base pairs that support 
efficient splicing.  The net result of these positive and negative factors, in this 
case, is that -1>0>+1 in terms of branching efficiency.  When two nucleotides 
proximal to helix Ia are deleted in this substituted U2, upstream bulge positions 
become favoured: of the -2, -1 and 0 bulges, -1 relatively favourable flanking 
sequence and, as it is also well positioned, becomes the most efficiently used 
branch position. 
 
Similar considerations to those applied above can explain the preference for 
branching from the 0 position in the pseudo-wt CG-substituted BS-U2 duplex 
(Fig. 4-11A&B), and indeed in the truly wild-type UACUAAC context.  The 
canonical BS in each context is an optimally positioned adenosine with 
favourable sequence context, and each of the flanking nucleotides is deficient in 
at least two of these respects; this allows what appears to be a relatively flexible 
active site capable of acting on suboptimal substrates to give rise to strong 
specificity.  In systems with less stringent branch site consensus sequences, 
even greater flexibility or different relative contributions of the various factors that 
determine branching efficiency could allow more promiscuous branching. 
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Because the spliceosome is robust, several deleterious changes may be required 
to generate a visible effect on splicing efficiency in vivo, particularly if these 
changes predominantly affect steps that are not close to being rate-limiting.  In 
the generation of an orthogonal BS-U2 system tailored for the investigation of 
nucleophile specification we show that, although BS-U2 pairing is required for 
splicing, the sequence of the BS and its cognate region of U2 are much less 
important.  Complete replacement of the BS-U2 duplex results in both 
spliceosome assembly and first step catalysis being partially limiting; this allows 
a systematic analysis of the determinants of branch nucleophile use.  We identify 
three major determinants of branching efficiency: the identity of the branch 
nucleotide (and to a lesser extent the identity of flanking base pairs), the position 
of the bulged branch nucleotide within the BS-U2 duplex and, independently, its 
position relative to the U2 component of U2/U6 helix Ia. 
 
In a case in which multiple unpaired adenosines are present with little potential 
for downstream pairing to U2, branching occurs at the first unpaired A (Fig. 4-
8D).  This suggests that, although appropriate positioning of a bulge relative to 
the catalytic core provides the strongest determinant for efficient branching, a 
single-stranded nucleotide at the edge of a helix can also act as a branch 
nucleophile.  The distribution of mapped branch positions in the U12 spliceosome 
(148) obeys similar rules, with the strong features being a well-defined BS-U12 




The branch site adenosine of a pre-mRNA can be bulged from almost any 
Watson-Crick duplex, as indicated by the observation that virtually all BS-U2 
pairs we tested were functional.  The extreme conservation of the BS-binding 
region of U2 (the GUA sequence opposite the bulged branch nucleophile is 
conserved between U2 and U12) is therefore not explained by a dependence of 
spliceosome function on a specific sequence.  The splicing defect of highly 
substituted BS-U2 pairs with an optimally positioned bulge appears to be 
predominantly due to impaired spliceosome assembly, as suggested by partial 
suppression by prp5 alleles, and to a lesser impact on splicing catalysis (Fig. 4-
9).  In contrast, BS-U2 pairs with a sub-optimally positioned bulge are 
catalytically defective, indicated by strong improvement by ATPase-defective 
prp16 alleles.  Thus, assembly is primarily affected by alteration of the BS-U2 
duplex, whereas catalysis is sensitive to altered positioning of the nucleophile. 
INDEPENDENT POSITIONING OF 5’SS AND BRANCH SITE 
If higher-order structures containing the branch nucleophile and 5’SS electrophile 
for the first step of splicing were fixed relative to one another, moving the branch 
nucleophile should alter the position of 5’SS cleavage.  We observe, however, 
that moving the branch nucleophile relative to the BS-U2 duplex or to helix Ia 
does not alter 5’SS selection, indicating that this is not governed by BS selection.  
This observation is in agreement with the ability of higher eukaryotic 
spliceosomes to cleave the same 5’SS at the same position using more than one 
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possible branch nucleotide (137), and highlights the commonality of substrate 
selection in the S. cerevisiae and metazoan spliceosomes.   
 
The position of branching within the BS-U2 duplex can impact the second step of 
splicing.  The precise mechanistic basis of the defect sometimes observed with 
non-zero branch positions and/or helix Ia-proximal insertions and deletions (e.g. 
Fig. 4-11) is unclear, especially as branching from non-zero positions (e.g. Fig. 4-
6D) and insertions into U2 (e.g. Fig. 4-1D) do not in themselves invariably lead to 
second step defects.  The role of U2 in the second step of splicing is given a 
fuller treatment in chapter 5.  
EVOLUTIONARY CONSIDERATIONS 
The spliceosome and group II self-splicing introns share a number of features 
that suggest a common evolutionary ancestor.  Support for significant overlap of 
catalytic mechanism between the two systems has recently been provided by the 
crystal structure of a spliced group II intron: in this structure, motifs that are 
conserved between group II introns and U6 snRNA (in which they are close to 
helix Ia) coordinate magnesium ions (118).  Our data extend this catalytic 
similarity by suggesting a conserved mechanism of branch nucleophile selection 
and positioning.  A branch site adenosine incapable of bulging cannot efficiently 
participate in first step branching catalysis in either system – Fig 4-1 and (140) – 
and the identity of flanking base pairs influences branching efficiency – Fig. 4-7; 
cf. Fig. 4-11&4-12 and (151).  In addition, the use of cryptic branch sites in group 
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II introns can be observed upon alteration of the distance between domains 5 
and 6, the equivalents of the U6 ISL and BS-U2 duplex, respectively (151).  In 
our BS-U2 system, the use of upstream bulges is favoured by deletions predicted 
to decrease the distance between the U6 ISL and the BS-U2 duplex, and 
disfavoured by insertions predicted to increase it (Fig. 4-11).  Thus, our data 
support a spatially similar organisation of conserved elements in group II introns 
and the spliceosome. 
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CHAPTER 5. DISCUSSION 
PREAMBLE: THE STRENGTH OF A FULLY SPLICESOMAL EXPERIMENTAL 
APPROACH TO SPLICING RESEARCH 
One of the original aims of my thesis work was to establish an RNA-only system 
that could be used as a model to bypass spliceosome assembly and investigate 
the catalytic phase of splicing, in order to generate hypotheses that could be 
tested in complete spliceosomes.  However, as discussed in chapter 2, a great 
deal of assumption and subjective judgement is inherent in this approach.  As will 
be discussed further below, the current extent of our knowledge of the active site 
of the spliceosome is such that even its composition remains an open question.  
Given such a combination of uncertainty and subjectivity, the use of rationally 
designed minimal experimental systems appears as likely to generate misleading 
results and hypotheses as informative ones; my subsequent work therefore 
focused on the use, almost exclusively in an in vivo context, of the established 
and powerful S. cerevisiae genetic system as a tool to investigate splicing 
catalysis.  Although in vivo and extract-based experimental work are not without 
their disadvantages, the relevance of results thus obtained is fairly easy to 
establish, even in the context of large and relatively poorly understood 
complexes such as the spliceosome. 
 
In one sense, the work described in chapters 3&4 follows well-worn conceptual 
paths: this work is, however, representative of the suite of approaches that will be 
required to further our mechanistic understanding of the splicing reaction.  In 
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chapter 3 the identification and characterisation of an aberrant product, in this 
case a hybrid RNA resulting from trans-splicing of U2 snRNA to a reporter gene, 
allowed us to draw mechanistic conclusions about the normal course of the 
reaction.  In chapter 4, our detailed investigation of the role of branch site-U2 
pairing in branching catalysis by the spliceosome was made possible by 
compensatory suppressor mutations. Rather than being an end in themselves, 
however, the suppressor pairs allowed us to establish a second-copy 
spliceosome, dissociating splicing efficiency from cellular viability and thus 
allowing us to combine a physiologically relevant in vivo environment with the 
mutational freedom of in vitro studies.  As will be discussed further below, we 
hope that this system can be extended and built upon in the future. 
 
Various direct conclusions resulting from the work described in this thesis have 
been discussed in detail in individual chapters.  In this chapter I will focus on 
more global implications of the work as a whole, as well as on open questions to 
which extensions of this work may provide answers. 
 
THE CHEMISTRY OF RNA BRANCHING 
In Chapter 4, we verified that adenosine is favoured as the branch site 
nucleotide, and that this preference is at least in part manifested during the 
catalytic phase of splicing.  The extraordinary complexity of the spliceosome 
compared to the simple reactions it catalyses suggests that specific contacts 
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likely enforce such sequence preference.  However, both the broad catalytic 
repertoire available to RNA implied by the work in Chapter 2 and considerations 
of spliceosome evolution from simpler progenitors merit consideration of the role 
of adenosine as a branch nucleophile in splicing and in unrelated branching 
reactions. 
 
Although, as discussed in Chapter 4, group II introns, the spliceosome and some 
in vitro evolved ribo- and deoxyribozymes display selectivity for adenosine as a 
branch nucleophile, such a preference is not universal among RNA branching 
reactions.  A natural ribozyme that forms a 2’-5’ bond as part of a 3 nt lariat cap 
structure uses uridine as a branch nucleotide (152), and artificial DNAzymes 
have been generated that efficiently branch from pyrimidine nucleotides (153).  
As noted by Silverman and colleagues (147), a commonality between enzymes 
that show a strong preference for a BS-A is that they are predicted to bulge the 
branch nucleotide for catalysis.  Consistent with this observation is the lack of 
involvement of an obvious bulge structure in the reaction described in Chapter 2, 
in which uridine is the preferred branch nucleotide.  The adherence of this 
ribozyme reaction to the observed pattern of behaviour despite the formation of a 
2’-3’ rather than a 2’-5’ bond suggests that the lack of a preference for a BS 
adenosine is a more general feature of transesterifications that do not involve 
bulged nucleophiles.  
  
120 
Adenosine is over-represented among bulged or unpaired nucleotides in solved 
RNA and RNP structures, with over 60% of adenosines unpaired in 16S rRNA 
structures compared to ~30% for each other nucleotide (154): while tertiary 
structure formation, for example the ability of unpaired adenosines to read 
Watson-Crick base-pair geometry via A-minor interactions (155) presumably 
partially accounts for this observation, it is possible that the intrinsic stability of 
adenosine-containing extrahelical bulges is also a factor.  A systematic analysis 
of the dependence of extrahelical bulge stability on nucleotide identity has, to our 
knowledge, not been carried out; such an analysis would have to be based on 
complex NMR and/or molecular dynamics due to the ability of single unpaired 
nucleotides to adopt several conformations: bulged (156), intercalated between 
the adjacent base pairs (157), engaged in a base triple with a flanking base pair 
(158) and possibly others.  Unpredictable effects of sequence identity outside the 
flanking base pairs on the relative stabilities of these structures (159) may further 
complicate this issue. 
 
Independently of the stability of RNA bulge structures, adenosine is inherently 
likely to be the most reactive nucleotide towards branching reactions because the 
pKa of its 2’ hydroxyl group is lower than that of the other three (160), resulting in 
more facile deprotonation for nucleophilic attack.  Enzymatic catalysis may, 
however, render considerations of intrinsic nucleotide reactivity moot.  Many 
studies have concluded that 2’ hydroxyl groups are up to a hundredfold more 
reactive towards transesterification or condensation reactions than 3’ hydroxyls, 
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both in template-free and template-directed non-enzymatic systems (161, 162), 
yet enzymatic systems with free nucleotide (for example group I introns) or 
oligonucleotide-terminal (for example RNA ligases and polymerases) RNA 
nucleophiles are capable of exquisite 3’ hydroxyl regiospecificity via substrate 
positioning and transition state stabilisation. 
 
RNA branching reactions from non-terminal nucleotides are limited in their choice 
of nucleophile to the 2’ hydroxyl group: such reactions can, however, theoretically 
generate either 2’-5’ or 2’-3’ linked products.  Although 2’-5’ branches should 
have lower energy transition states due to the greater acidity of the cis-diol 3’ 
hydroxyl than the primary alcohol 5’ hydroxyl (105), the reasoning applied above 
argues that this consideration is likely to be virtually irrelevant in an enzymatic 
context.  With this in mind, our knowledge of several natural systems that 
generate 2’-5’ branches and none that generate the 2’-3’-linked form is surprising 
and, as noted in Chapter 2, could reflect the relative difficulty of identifying and 
mapping 2’-3’ linkages rather than their absence from the range of naturally 
generated cellular RNAs.   
 
Mapping 2’-5’ branches, especially in a high-throughput manner, is not trivial for 
several reasons.  Reverse transcriptase can read through such branches, 
presumably with variable efficiency (163), and in addition both the 2’-5’ lariat 
debranching enzyme (164), and antibodies that recognise this branch structure 
(165) show strong sequence specificity: the branch antibody, for example, is 
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extremely selective for A2’-5’G branches.  Finally, nucleases that cleave more 
than 1 nt away from a branch (such a nuclease would allow the position of such 
branches, rather than simply their existence, to be inferred) have not been 
identified or generated.  This mapping challenge is even greater for 2’-3’ 
branches: antibodies, debranching enzymes and nucleases that leave sequence 
tags are all lacking for this structure.  In addition, reverse transcriptase, in theory 
capable of mapping the branch site only on the 2’ donor strand, can read through 
such branches (105) although nothing is known about the efficiency of this 
readthrough.  To date only directed, labour-intensive and imperfect 
methodologies have been used to identify 2’-3’ branches.   Direct, positionally 
specific labelling followed by nuclease digestion, as exemplified in Chapter 2, can 
reliably map branches but is limited to in vitro reactions and is only practical if the 
locations of the reactive sites have already been narrowed down.  The existence 
of 2’-3’ branches in cellular RNAs could be confirmed via sequential 
overdigestions with lariat debranching enzyme and P1 nuclease, but information 
regarding the sequences of the RNAs involved in such linkages would be lost.  
Given that no high-throughput methodology for 2’-5’ branch mapping has been 
forthcoming despite the existence of pressing and long-standing mechanistic 
questions regarding mammalian branch site use in pre-mRNA splicing, we are 
not optimistic about the imminent development of such techniques for 2’-3’ 
branches. 
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ADDING TEMPORAL RESOLUTION TO OUR KNOWLEDGE OF 
SPLICEOSOMAL INTERACTIONS 
Much work in the mechanistic splicing field is justifiably focused on the 
generation of spliceosome preparations suitable for X-ray crystallography.  The 
high-resolution structures that will hopefully result from this work should resolve 
many questions, and provide invaluable information about the mechanistic details 
of the splicing reaction.  The preparation of large quantities of sufficiently pure, 
conformationally homogeneous spliceosomes, however, remains a serious 
challenge.  Further and more detailed knowledge of the dynamic behaviour of the 
spliceosome will aid such crystallographic efforts, and will also be necessary for 
the rationalisation and accurate interpretation of their results.  The branch site-U2 
interaction, as the focus of this work, illustrates many of the challenges posed by 
the dynamic spliceosome and our imperfect knowledge of the conformational 
states during which specific interactions are relevant.   
 
This work unequivocally shows that BS-U2 pairing is required to bulge and 
activate the BS nucleophile for first step catalysis (Chapter 4). The use of sites in 
the branch site binding region of U2 as 5’ splice sites for both steps of splicing 
(Chapter 3) suggests that the BS-U2 pairing established during spliceosome 
assembly does not, as previously assumed, persist after the first catalytic step.  
The fine details of our analysis, however, indicate substantial further complexity.  
That multiple trans-spliced sites exist in U2 (Fig. 3-5) implies that at least one 
state exists between the establishment of BS-U2 pairing and the first catalytic 
step in which the branch site is unpaired from U2.  This should perhaps not be 
124 
surprising due to the long and complex nature of the spliceosome assembly 
pathway: it is known that U2 toggles between its stem IIa and IIc forms during 
assembly (48, 49), and the canonical BS-U2 interaction may toggle similarly, 




Figure 5-1.  Spliceosomal side reactions and conformational toggling. 
Schematic depiction of the observed and potential reactions occurring during 
reversible splicing catalysis by compositionally homogeneous spliceosomes, as 
described in (59).  Interactions that may toggle during the splicing pathway, as 
well as the effect of potassium ions on certain states, are noted underneath. 
 
Despite the apparent lack of a requirement for BS-U2 base pairing for exon 
ligation by the spliceosome, U2 must play a role in this step.  Crosslinks have 
been observed between the 3’SS and helix I-proximal nucleotides in U2 (166), 
and insertions around the U2 component of helix Ia block the second step in vitro 
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(167, 168).  In addition, moving the branch nucleophile within the catalytic centre 
often imposes a second step block (cf. Fig. 4-3, 4-11&4-12). It is possible that 
this defect is at least partially due to the formation of a non-canonical branch.  
The formation of the branch structure likely eliminates the positional and 
rotational flexibility of the BS-U2 duplex; this in turn could influence the 
repositioning of the branch structure that is required for entry into the second 
step (44).  An aberrant branch may not reposition efficiently, perhaps due to a 
poor fit with the second step binding site that likely exists for the lariat branch; 
alternatively, the disruption of the BS-U2 duplex suggested by the data shown in 
chapter 3 may be inhibited.   
 
The lariat branch is almost certainly specifically bound during the second step of 
splicing, but the nature of its binding site is unclear.  Between the two catalytic 
steps, the 5’SS is thought to move to a new binding site on U6 snRNA 5 nt 
upstream of its first step site.  Given that the 5’SS and BS are covalently linked at 
this stage in the reaction, movement of the BS is presumably a necessary 
corollary of 5’SS repositioning.  An appealing possibility is that the BS could 
move 3nt along U2, such that the 5’-UACUAAC-3’ branch sequence paired with 
the second GUA repeat in the U2 5’-GΨAGUA-3’ BS-binding sequence rather 
than the first.  Such repositioning would also be consistent with the observed 
5’SS use during trans-splicing, as the downstream-most 5’SS in U2 is at 
GΨA/GUA. We have, however, been unable to find genetic evidence in support 
of a 3 nt repositioning event: BS-U2 pairs incapable of forming the putative 
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second step interaction display no exon ligation defect (Fig. 4-4C), even in the 
context of a 3’SS mutation that should make the second step limiting for overall 
splicing (data not shown).  In a less hypothesis-driven line of experiment, we 
attempted crosslinking-based experiments to identify the second-step binding 
site of the BS-side of the lariat branch.  A UBC4 RNA site-specifically derivatised 
with 4-thio-uridine (UAC[4SU]AAC) did not detectably crosslink to any snRNAs: 
the synthesis of a similarly derivatised version of actin, for which the second step 
is less efficient and which may therefore represent a more promising substrate, 
proved too inefficient  to be experimentally feasible (data not shown).   
 
The importance of establishing the temporal details of spliceosomal interactions 
is clear.  Tseng and Chen, referring to the effects of ionic environment on the 
efficiency of various splicing reactions in vitro (59), note that the selective 
stabilisation of spliceosomal conformations via modulation of salt conditions will 
facilitate the enrichment of defined states for experiments such as snRNA 
secondary structure mapping and hopefully crystallography; hyperstabilisation of 
combinations of interactions unique to a given state would allow further 
enrichment, and should also help to inhibit the reverse and side reactions (some 
such reactions are indicated in Fig. 5-1) observed to occur in stalled 
spliceosomes, which will otherwise severely diminish homogeneity.  As a final 
note, and as alluded to in chapter 1, the large number of conformational 
transitions that appear to be necessary for splicing may render difficult the 
interpretation of the high-resolution crystal structures we hope will become 
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available in the future.  Knowledge of the RNA-RNA interactions particular to 
each state of the spliceosome will help to alleviate these difficulties. 
GENERATING NEW AND EXTENDED ORTHOGONAL SPLICING SYSTEMS 
Many important mechanistic analyses of splicing have been carried out in vitro; 
the purity and lack of constraint of such biochemical approaches, often offset by 
technical difficulties and the unnatural environment inherent in all in vitro work, 
can be recapitulated in vivo by nonessential spliceosomes that do not impact 
endogenous splicing.  Further such spliceosomes, both derived from that 
described here and entirely novel, could prove to be invaluable in the continuing 
analysis of the catalytic phase of splicing. 
 
The analysis of branch site-U2 interaction described in chapter 4 builds on 
previous genetic analyses of the spliceosome, employing compensatory base 
pairs and second copy mutants; these approaches have previously identified and 
validated many RNA-RNA interactions in both the yeast and human 
spliceosomes (61, 149, 169, 170), and the concept of using compensatory 
mutations is clearly not novel in itself.  However, our system is distinguished by 
its conception to address a specific mechanistic question regarding splicing 
catalysis, rather than to identify/validate an intermolecular interaction.  In 
addition, our results show the acceptability of gross sequence substitutions within 
an extremely conserved element in the core of the spliceosome.  The minor 
spliceosome can be thought of as a natural example of an orthogonal BS-U2 
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system, specific for a subset of introns.  This system relies on several dedicated 
interactions (e.g., U11-5’SS, U12-BS, U12-U6atac), suggesting that analogous 
extensions to our system should be feasible.  We hope that other highly 
conserved interacting partners will be similarly amenable to substitution; this will 
allow the generation and in vivo analysis of spliceosomes with more and/or 
different components separate from the endogenous splicing machinery.   
 
The most obvious candidate for a second component to be incorporated into 
orthogonal spliceosomes is U6 snRNA.  As previously discussed, U6 forms 
several intermolecular base pairs with U2 snRNA and, although these 
interactions may be more dynamic than predicted by current models of the 
spliceosome active site, the requirement of such structures for cellular viability 
(61), the existence of a dedicated U6 snRNA in the minor spliceosome, and the 
data presented in chapter 3 (cf. Fig. 3-4), suggest the feasibility of generating 
rationally designed U2/U6 pairs (Fig. 5-2A&B).  Thus far, however, our attempts 
to incorporate dedicated second-copy U6 snRNAs into our system have been 
unsuccessful, with mutant U2 molecules appearing to work equally well with wild-
type U6 as with their intended mutant partners (two representative helix Ia 
mutants are shown in Fig. 5-2C; gross substitutions throughout helices I and II 
have been tried).   
129 
 
Figure 5-2. Initial attempts to incorporate U6 into the orthogonal BS-U2 
system. 
Schematics depicting the nature of wild-type (A) and orthogonal (B) 
spliceosomes.  The orthogonal spliceosome in [B] contains U2 snRNA with a 
substituted BS-binding region and a mutations in helix Ia that are inviable in vivo 
in the absence of compensatory mutations; mutant U6 contains these 
compensatory changes in helix Ia.  Only wtU2-wtU6 and mutU2-mutU6 pairing 
should be possible.  (C) Primer extension on total RNA from strains carrying 
substrates with all-CG branch sites and U2/U6 pairs with two representative sets 
of helix Ia mutations.  The intended specificity of wild-type and mutant snRNAs 
for their pairing partners is insufficient for the incorporation of mutant U6 into 
spliceosomes containing mutant U2. 
 
In general, second-copy mutant U6 snRNAs show much weaker effects than do 
second-copy U2s, likely due to very low-level expression of the mutant allele  
(Charles Query and Magda Konarska, unpublished data); this could be a factor 
underlying our current inability to incorporate U6 into our system.  If poor 
expression does indeed at least partially underlie the problem, it is likely that a 
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simple solution exists – expression of U6 from a higher copy-number plasmid or 
different promoter, for example, may be sufficient to allow strong expression of 
mutant U6 snRNAs.   
 
Weak expression of mutant U6 alleles is not the only impediment to the 
establishment of an orthogonal U2/U6 system. From Fig. 5-1C it is clear that both 
wild-type and mutant U6 can be incorporated into functional spliceosomes with 
mutant U2, possibly suggesting that U2/U6 pairing does not limit the splicing of 
our mutant reporters and that the spliceosome can therefore tolerate a lack of 
pairing in helix I or II.  It may therefore be necessary to incorporate additional 
mutations that impair the formation of catalytic spliceosomes containing 
mismatched U2 and U6 molecules.  An intuitive approach, reminiscent of 
experiments used to identify helix III (149), would be to use a reporter gene 
carrying a mutated 5’SS in addition to its substituted BS, and for the mutant U6 to 
carry a complementary substitution (e.g. 5’SS position G5 and U6 position C48) 
in addition to helix I/helix II mutations.  One potential pitfall of this approach may 
be the detrimental effects of multiple substrate and spliceosome mutations on 
splicing efficiency – grossly substituted reporters are already spliced at least 
threefold less efficiently than wild-type reporters (Fig. 4-4). 
 
U5 snRNA, Prp8 and various components of the NTC (for example, Cef1) 
represent further desirable targets for work in this direction.  Our incomplete 
knowledge of intermolecular interactions within the spliceosome will, however, 
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make the incorporation of these components more challenging than is the case 
for U6 snRNA, and will almost certainly preclude rational design.  It is possible 
that non-hypothesis-driven approaches such as genetic screens may allow us to 
identify, for example, Cef1 alleles that only function in the context of substituted 
U2 and U6 molecules.  If such screens prove to be successful, the utility of our 
system be greatly extended: additionally, the mutations required for the chosen 
components to function in the mutant spliceosome should be informative in 
themselves. 
DEXD/H-BOX ATPASES 
Although it is known that each ATPase-mediated step in the splicing pathway 
affords an opportunity for either discard or progression, the molecular details of 
how these are achieved are unclear.  As noted in chapter 1, it is not known 
whether the precise molecular changes that induce progression are the same as 
those that lead to discard if the preceding step has not been completed: in 
addition, while helicase activity is often assumed to underlie the effects of these 
proteins, the identification and validation of direct targets has proved challenging.    
 
Many DExD/H ATPases, both spliceosomal and non-spliceosomal, have been 
shown to have RNA unwindase activity correlating with ATPase activity in vitro: 
among the spliceosomal ATPases, Brr2, Prp16 and Prp22 (93, 171, 172) have 
been directly demonstrated to possess such helicase activity. Brr2, which acts at 
the stage of U4 dissociation from the spliceosome, can unwind U4/U6 in vitro; 
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this activity is greatly stimulated by a fragment of Prp8 (74), and appears likely to 
be physiologically relevant. It is therefore tempting to speculate that each 
ATPase is associated with the disruption of a single RNA duplex. 
 
Despite the example of Brr2, it is unclear whether ATPase/unwindase activity is 
the mechanistic basis of all spliceosomal activity of DExD/H ATPases. Although 
conserved helicase activity is suggestive, the possibility that not all of these 
proteins rely on this activity to modulate spliceosomal transitions should not be 
discounted. ATPase-defective prp28 alleles impose a block on the splicing 
pathway, inhibiting the release of U1 and U4; this is also inhibited by 
hyperstabilisation of the duplex formed between the 5’SS and U1 snRNA (60).  
Such data could be taken to imply that the role of Prp28 is to unwind the U1-5’SS 
duplex; these observations, however, could be coincidental: inhibition of similar 
or even identical steps on the splicing pathway by different mutations does not 
necessarily indicate mechanistic identity.  Prp22 has been proposed to stimulate 
mRNA release by the spliceosome by first binding downstream of the 3’SS, then 
translocating along the 3’ exon and disrupting the base pairing between U5 
snRNA and the newly spliced exons (173); this hypothesis, however, is based on 
genetic interactions between prp22 alleles and those of other spliceosomal 
components (U5, Prp8, Slu7) (52, 174) reminiscent of the interaction between 
prp22 and prp8 alleles discussed in the context of chapter 1, whose effects are 
likely indirect (47).   
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Data from non-spliceosomal DExD/H ATPases makes matters still more 
complex.  Cyt19, a DExD/H protein that promotes group I intron splicing in vivo 
and in vitro, does so by acting as a non-specific chaperone, resolving kinetic 
traps along the folding pathway (175); similarly, splicing of the ai5γ group II intron 
in S. cerevisiae is stimulated by Mss116, and splicing activity in vitro correlates 
with Mss116 ATPase and unwinding activity (176).  However, the same study 
reported a residual, ATPase-independent unwinding activity for Mss116, and 
recent data suggest that Dbp5, which is involved in mRNA export, functions to 
remodel RNPs only in its ADP-bound form, with ATP hydrolysis thus acting as a 
conformational switch rather than a power stroke (177).   
 
Even if some spliceosomal ATPases exert their effects through helicase activity, 
it need not necessarily be the case that all do.  The ability of these proteins to 
bind nucleic acids, together with the profusion of RNA in both the spliceosome 
and its substrate, however, make it almost inevitable that their association with 
the spliceosome will depend heavily on protein-RNA interactions.  An obvious 
implication is that RNA structures specific to a given stage of the reaction are at 
least as likely to be recognised by relevant ATPases as they are to be unwound.  
Indeed, the recognition of stage-specific structures could even help to stimulate 
ATPase-mediated rearrangement (again, regardless of whether or not this 
includes active duplex unwinding via helicase activity).  Such stimulatory action 
could theoretically act as a mechanism to increase the rate at which optimal 
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substrates react, akin to the specific rate acceleration observed for cognate 




Figure 5-3.  Effects of different prp5 alleles on grossly substituted BS-U2 
pairs. 
Primer extensions on CGCCGAC reporters with BS adenosines bulged from the 
-1, 0 or 1 positions, grouped by prp5 allele.  The -T448G (SAG) mutant impairs 
splicing of the 0 position reporter, presumably by increasing discard, while the –
N399D mutant increases splicing efficiency. 
 
The behaviour of the grossly substituted BS-U2 pairs described in chapter 4 in 
combination with different alleles of prp5 may offer support for a model in which a 
transition mediated by ATP hydrolysis by Prp5 is stimulated by a wild-type BS-U2 
duplex.  The prp5–SAG and –N399D mutants, both isolated by Xu and Query as 
suppressors of splicing defects due to single mismatches in the BS-U2 duplex 
(36), show distinct effects on the splicing of grossly substituted reporters (Fig. 5-
3).  prp5-N399D strongly improves splicing, while prp5-SAG inhibits it, with 
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substrate discard instead appearing to predominate.  A crucial difference 
between these two prp5 alleles is that –SAG is ATPase-defective, while –N399D 
is not (36).  The behaviour exhibited in Fig. 5-3 is consistent with the failure of the 
substituted BS-U2 duplex to stimulate ATPase activity, leaving too little residual 
activity for efficient progression in the context of the already defective –SAG 
allele, but sufficient activity in the context of –N399D (whose mechanism of 
suppression remains unknown).  Of course, while this result is consistent with the 
hypothesis that Prp5 is stimulated by the wt BS-U2 duplex, the same caution of 
interpretation stressed in relation to Prp28 and Prp22 is required.  It is worth 
noting, however, that recognition and unwinding of the BS-U2 duplex by Prp5 
could give rise to the apparent pre-first step unpairing of the branch site (chapter 
3). 
THE NATURE OF THE SPLICESOMAL ACTIVE SITE(S) 
The data presented in chapter 4 suggest similarity in the spatial organisation of 
various active site and substrate elements between group II introns and the 
spliceosome.  These splicing systems, which catalyse the same two chemical 
reactions, are thought to be evolutionarily related.  As noted in previous chapters, 
a great number of similarities beyond simple mechanistic identity stand in support 
of this hypothesis (these data have already been detailed, and will not be re-
stated here).  The generally accepted evolutionary link between group II introns 
and the spliceosome has led to the almost equally global inference that the 
spliceosome must be a ribozyme – that is, that the divalent metal ions 
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presumably required (114) for the catalytic steps, as well as the pre-mRNA 
nucleotides involved in these reactions, are bound directly by snRNA.  
  
A critical difference between the splicing activities of group II introns and the 
spliceosome is that, while each group II intron catalyses its own removal in a 
single-turnover reaction, the spliceosome must assemble and perform catalysis 
in trans on diverse intron substrates.  Specificity that can be attained by 
intramolecular folding in group II introns must be established and maintained via 
other mechanisms during spliceosomal splicing.  Given that splicing must occur 
in trans, and that accurate splicing is essential for viability in all known 
eukaryotes, it is reasonable to speculate that substrate recognition may be more 
complex in the spliceosome than in self-splicing introns.  Consistent with such 
increased complexity of selection, increasing the distance between domains V 
and VI in group II introns can activate both ectopically bulged branch adenosines 
and more conventionally defined cryptic branch sites (151), while in the 
spliceosome (at least in S. cerevisiae), changing the distance between the 
equivalent structures only gives rise to the former (chapter 4).   
 
Repeated recognition of a motif can, if mediated via different interactions, 
generate increased substrate selectivity (179).  The protracted assembly and 
activation phase required for spliceosome action thus presumably serves to allow 
effective discrimination between substrates as well as presenting multiple points 
of regulation.  One of the key mediators of selectivity is likely to be Prp8, the 
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largest and most highly conserved protein in the spliceosome, which contacts 
each of the three reactive substrate sites at some stage during the reaction (50).  
Intriguingly, the C-terminal domain of Prp8 has recently been shown 
independently by three groups to adopt an RNase H fold (121-123); this domain 
has previously been shown to contact the GU dinucleotide at the 5'SS (180), and 
binds a structured RNA reminiscent of proposed intron-snRNA complexes (122).  
Although the residues corresponding to the RNase H active site do not conform 
to the consensus or bind metal ions in any of these crystal structures, a similar 
active site arrangement can be found in catalytically active RNase H domains, as 
noted by MacMillan and colleagues (122).  This raises the possibility that Prp8 
may directly participate in one or both steps of splicing catalysis rather than 
solely contacting splice sites during assembly.  It may therefore be the case that 
splicing catalysis, as well as assembly of the relevant enzyme, is more complex 
in the spliceosome than in group II introns.  Regardless of Prp8’s direct 
contribution to catalysis, the intimate involvement of this and other proteins 
means that, even if the metal ions required for splicing catalysis are coordinated 
entirely by groups from snRNAs, the spliceosome might most productively be 
considered an RNP with an RNA active site, rather than a ribozyme. 
 
Splicing catalysis, comprising two sequential transesterification reactions, almost 
certainly makes use of two metal ion catalysis (114).  As part of their exhaustive 
analysis of the ionic requirements for forward and reverse splicing, Tseng and 
Chen have investigated the effects of divalent metal ions on the efficiency of 
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each step (59).  The results indicate that Ca2+ or Mn2+ can substitute for Mg2+ for 
R1 (first step reversal); Mn2+ can support F2 but with relaxed specificity relative to 
Mg2+, and only Mg2+ can support R2.  Mn2+ or high pH, both of which fail to 
support R2, instead appear to catalyse spliced exon reopening (SER) – a 
reaction first identified in self splicing introns (181, 182) and considered to be a 
reversal of the second step in which water, rather than the 3’ end of the excised 
intron, acts as the nucleophile.  The distinct catalytic capabilities of divalent metal 
ions suggest subtle differences in active site requirements for the two steps of 
splicing, although the effects of different ions could be either direct – resulting 
from coordination of these ions in the active site itself, or indirect – resulting from 
more global structural differences due to coordination of these ions at other sites 
in the spliceosome.  Stereochemical evidence has been used to argue for two 
spliceosomal active sites (183), even if at least some key elements are shared 
between the two. The involvement of a given motif in one step does not 
necessarily indicate a role in the other, and it remains to be clarified how similar 
the active sites for the two catalytic steps are: although much genetic, 
biochemical and structural work remains to be carried out, answers are hopefully 






MATERIALS AND METHODS 
IN VITRO TRANSCRIPTION AND TRANSCRIPT PURIFICATION 
Transcription templates were prepared either by PCR, adding the [T7 promoter + 
start] sequence CGCGTAATACGACTCACTATAGGGAAAGCT to the 5’ end of 
the amplified product, or by cloning into the pDrive vector (Qiagen), which 
contains a T7 promoter.  Where homogeneous 3’ ends were required, templates 
were prepared by PCR using an antisense primer in which the 5’-most two 
nucleotides carried 2’-OMe substitutions, as this prevents the addition of non-
templated adenosine nucleotides to the 3’ end of the transcript by T7 
polymerase.  Transcription was carried out using 2 µl of the lab stock of T7 
polymerase and 1 µg template DNA per 10 µl reaction for 2-4h at 37 ˚C in 1x 
transcription buffer (40 mM Tris-HCl, pH 8.0, 8 mM MgCl2, 2 mM spermidine-
HCl, 50 mM NaCl, 10 mM DTT).  NTPs were present at 1 mM each and 
supplemented with radiolabelled NTP unless high specific activity was desired, in 
which case the unlabelled NTP corresponding to the label was at 130 µM. 
Reactions were stopped by the addition of 5 U DNaseI and incubation at 37 ˚C 
for a further 30 min.  Generally, transcripts were purified from 
polyacrylamide/urea gels (if larger than 20 µl, they were first extracted and 
precipitated to reduce their volume).  An equal volume of deionized formamide 
containing bromophenol blue and xylene cyanole was added to the DNase-
treated reaction, this was heated at 95 ˚C for 2 min, then loaded into the gel.  Gel 
slices of interest were excised, crushed, and rotated overnight at 4 ˚C with 400 µl 
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each of Tris-phenol and 0.3 M NaOAc, pH 5.5.  The aqueous phase was 
collected, avoiding gel fragments, and 20 µg glycogen and 40 µl 3M NaOAc, pH 
5.5 added before ethanol precipitation. 
TRANSCRIPT LABELING AND QUANTITATION 
Transcripts were generally body-labeled with either [α32P]-U- or ATP and 
quantitated via scintillation counting (Cerenkov) Vs the stock nucleotide, which 
served as a standard of known concentration and activity. Where accurate 
quantitation of non-radioactive transcripts was required, small aliquots of 
transcription reactions were generally removed immediately after addition of 
polymerase, and spiked with a known amount of [α32P]-UTP.  These spiked 
aliquots were processed and purified alongside their parent reactions.  
OLIGONUCLEOTIDE LABELLING AND PURIFICATION 
5’ end-labelling was carried out using T4 Polynucleotide kinase (PNK). 15 µl 
reactions contained 1 µl Tris-HCl pH 7.5, 1 µl 200 mM MgCl2/34 mM spermidine-
HCl, 1 µl 0.3M β-Mercaptoethanol, 1 µl T4 PNK, 10 µl [γ32P]-ATP (normally 3000 
Ci/mmol) and 1 µl oligonucleotide diluted to produce a labeled stock of the 
desired specific activity (generally 100 µM for low, 20 µM for high, and 5 µM for 
very high).  Reactions were normally either 7.5 or 15 µl, and ran at 37 ˚C for 30-
120 min depending on the desired yield and the nature of the substrate (RNA or 
DNA).  Short internally labeled substrates, including those with a 3’-appended 
*pCp, were prepared by ligation with T4 RNA ligase.  The downstream ligation 
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substrate was kinased as normal (7.5 µl reaction, low S.A to use up all the [γ32P]-
ATP): this was heated to 65 ˚C for 3 min to inactivate PNK, followed by the 
addition of 0.5 µl 100 µM stock of the upstream ligation substrate, 1.1 µl 10x RNA 
ligase buffer (NEB) and 2 µl T4 RNA ligase.  Ligation reactions were incubated at 
37 ˚C for 40-180 min.  End-labeled substrates were generally, and internally 
labeled substrates always, purified from polyacrylamide/urea gels. 
 
SITE-SPECIFIC LABELLING OF LONG RNAS 
Ligation fragments were purified transcripts (prepared with homogeneous 3’ 
ends) and derivatised oligonucleotide, 5’ end-labelled at very high specific 
activity.  DNA splint oligonucleotides, capable of forming at least 15 base pairs 
with each substrate to generate a nicked duplex of length >30 bp were used.   
Both ligation substrates were quantitated, and were mixed in a 1:1 molar ratio 
with 0.8 molar equivalents of the DNA splint oligonucleotide.  AB buffer (see 
primer extension) was added to a final concentration of 0.5x, and the mixture 
heated to 95 ˚C, cooled slowly to 50 ˚C and placed briefly on ice.  T4 RNA ligase 
2 buffer was added such that its final concentration would be 1x, followed by 20 
U T4 RNA ligase 2 (NEB).  Reactions were supplemented by the addition of 
unlabelled ATP to a final concentration of 0.5 mM, and incubated at 37 ˚C for 2 
hr.  Products were purified from polyacrylamide/urea gels. 
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RNA OLIGONUCLEOTIDES 
RNA oligonucleotides were ordered from Oligos Etc. (TBDMS chemistry) or from 
Dharmacon (2’ ACE chemistry or 4-thio-uridine modifications), and were treated 
according to the manufacturer’s instructions. 
PROTEIN-FREE SPLICING REACTIONS 
~20-1000 fmol labeled BS oligonucleotide (50k-3M cpm) and >1000 fmol U26 
was used for each reaction.  A typical reaction was 5-10 ml and contained 50 mM 
Tris-HCl pH 7.2, 40 mM MgCl2, 200 mM KCl. The mixture was heated to 95 ˚C, 
cooled slowly to room temperature, left for 1-24h, ethanol precipitated and 
separated in a 20% polyacrylamide/8M urea gel. 
PARTIAL ALKALINE HYDROLYSIS AND DIGESTION OF RNA. 
For partial hydrolysis, RNA was heated at 95 ˚C for 5-20 min (somewhat length 
and sequence-dependent) in 50 mM Na2CO3, pH9.2. RNA to be digested was 
mixed with 1 µl yeast total RNA (corresponding to 1 30th the amount of RNA 
purified from a saturated 10 ml yeast culture in minimal medium), and digested 
for 1h according to the conditions below: 
RNase Amount Buffer Temp (˚C) 
A 1 µg 50 mM Tris-HCl, pH 7.5 37 
T1 2U 50 mM Tris-HCl, pH 7.7 37 
T2 1 µg 50 mM NaOAc, pH 5.5 50 
P1 nuclease 0.5 µg 50 mM NaOAc, pH 5.5 50 
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THIN LAYER CHROMATOGRAPHY 
Solvents for 2-dimensional thin layer chromatography were as follows: dimension 
1 – 57.7% n-butyric acid, 0.9% ammonium hydroxide in H2O; dimension 2 – 70% 
isopropanol, 15% conc. HCl in H2O.  Plates were loaded 1 µl at a time with 5 µl of 
the appropriately digested RNA, followed by 1 µl of markers (generally Np or pN) 
at 1 mM each.  Plates were dried completely between dimensions by sitting on a 
50 ˚C hotplate for at least 8 hours. The solvent for DEAE TLC was 0.2 M 
ammonium formate, 1 mM EDTA, 9M urea.  All plates were dried thoroughly and 
wrapped in cling film before autoradiography. 
CLONING AND PLASMID GENERATION/SHUTTLING 
Plasmids were generally prepared by gap repair recombination in S. cerevisiae 
strain 46ΔCUP.  A PCR insert containing the desired mutations was generated, 
and yeast transformed with this product and a cut vector before auxotrophic 
selection.  Briefly, 30 µl competent cells were incubated in 140 µl transformation 
buffer (40% PEG-3500, 0.1 M LiOAc supplemented with 10 µg boiled salmon-
sperm DNA) with 1 µg cut vector and 1/10 of a phenol:chloroform extracted and 
ethanol precipitated 100 µl PCR reaction. Plasmids were isolated from yeast and 
transfected into E. coli as follows.  5ml cultures were grown in the appropriate 
minimal medium and collected by spinning at 3500 rpm for 5 min.  Cells were 
resuspended in 200 µl STET buffer (8% sucrose, 50 mM Tris-HCl, pH 8.0, 50 
mM EDTA, 5% Triton X-100), and 200 µl acid-washed glass beads (Sigma) 
added.  Tubes were vortexed at maximum power for 5 minutes, heated to 95 ˚C 
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for 3 min, cooled on ice and the supernatant (150 µl) from a 10 min 14000 rpm 
spin at 4 ˚C collected to a tube containing 150 µl 4M NH4OAc.  This was 
incubated at -20 ˚C for at least 1hr, and the supernatant (300 µl) from a 10 min 
14000 rpm spin at 4 ˚C collected.  DNA was precipitated for at least 1hr at -80 ˚C 
with 30 µg glycogen and 450 µl ethanol.  DNA pellets were dried thoroughly and 
resuspended in 21 µl H2O.  7 µl were used for transformation into chemically 
competent bacteria, or 2 µl into electrocompetent bacteria.  Following a standard 
miniprep (using a Qiagen kit) and sequencing, plasmids were transfected into the 
appropriate yeast strain using a protocol identical to that used for gap repair. 
YEAST STRAINS USED 
Strains used in this work were Y04999 [MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; 
YKL149c::kanMX4] (derived from BY4741),  46DCUP [MATa, ade2 cup1Æ::ura3 
his3 leu2 lys2 trp1 ura3, GAL+], yCQ62 [MATa ade2 cup1Δ::ura3 his3 leu2 lys2 
trp1 ura3 snr6Δ::loxP snr20Δ::loxP, pU6+U2 (SNR6 SNR20 URA3 CEN ARS)], 
yCQ64 [MATa ade2 cup1Δ::ura3 his3 leu2 lys2 trp1 ura3 snr6Δ::loxP 
snr20Δ::loxP YKL149cΔ::loxP, pU6+U2 (SNR6 SNR20 URA3 CEN ARS)], yZX02 
[MATa ade2 cup1Δ::ura3 his3 leu2 lys2 trp1 ura3 prp5Δ::loxP] and yCQ08 [MATa 
ade2 cup1Δ::ura3 his3 leu2 lys2 trp1 ura3 prp16Δ::loxP]. 
YEAST TOTAL RNA PREPARATION 
Yeast cultures were picked to 1 ml cultures of minimal medium lacking the 
appropriate supplements.  These were grown to saturation at 30 ˚C, an aliquot 
145 
taken for copper growth assays (see below), and an aliquot used to inoculate a 
10ml culture of the same minimal medium.  10 ml cultures were grown to late 
log/early stationary phase before processing.  Cells were collected by 
centrifugation at 3500 rpm for 5 min at 4 ˚C, washed once with water, transferred 
to 1.5 ml tubes, and kept on ice before being transferred to -80 ˚C for at least 20 
min.  To the still-frozen cell pellets were added, in order, 420 µl Tris-phenol, 42 µl 
10% SDS, 420 µl AE buffer (50 mM NaOAc, pH 5.5, 10 mM EDTA).  The tube 
was vortexed until the cell pellet was fully resuspended, then placed at 65 ˚C for 
4.5-6.5 min (pressure was released from the tube, and the mixture vortexed, after 
~1.5 min).  After a brief vortex and a 5 min microfuge spin at 14000 rpm, 2x 
180 µl of the aqueous phase was collected (in order to clear the aqueous phase, 
each sample was heated to between 60 and 75 ˚C for ~30 sec before collection) 
into a tube containing 180 µl 50:50 phenol:chloroform.  This was spun at 14000 
rpm for 5-10 min in a microfuge, and 2x150 µl of the aqueous phase collected to 
a tube containing 30 µl 3M NaOAc, pH 5.5 and precipitated with 1 ml EtOH.  
Nucleic acid pellets were resuspended in 30 µl water before use. 
This RNA preparation protocol contains two potential pausing points: cells can be 
frozen at -80 ˚C for at least 6 months with no detrimental effect on RNA quality, 
and the phenol/SDS/AE mix, after heating, can be quick-frozen on dry ice and 
stored at -80 ˚C at least overnight. 
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PRIMER EXTENSION  
1.2 µl of a yeast total RNA prep was added to 5 µl radiolabelled primer (20k-
200kcpm undecayed, depending on the specific activity of the primer and the 
desired sensitivity of the reaction) in 1x AB (annealing buffer: 50 mM Tris-HCl, 
pH 8.3, 60 mM HCl, 10 mM DTT).  Tubes were placed in a 95 ˚C heat block on 
the benchtop, which cooled slowly to 50 ˚C: at 70 ˚C, tubes were spun in a 
nanofuge for 5 sec to collect liquid that had evaporated and condensed on the 
lid.  At 50 ˚C, tubes were placed on ice for 1-3 min, followed again by a brief spin.  
To the 6.2 µl reaction was added 6 µl 2.5x dNTPs (all 4 dNTPs at 200 µM each, 
in 1x AB) 3 µl 5x RT buffer (250 mM Tris-HCl, pH 8.3, 300 mM NaCl, 150 mM 
MgOAc, 50 mM DTT) and 3 µl AMV RT (diluted 1:50 from the purchased stock in 
0.2 M KHPO4, pH 7.2, 2 mM DTT, 0.2% Triton X-100, 50% glycerol in H2O).  The 
mixture was incubated at 42 ˚C for 20-80 min then either mixed with an equal 
volume of formamide + dyes or ethanol precipitated and resuspended in this, 
then loaded onto a denaturing polyacrylamide gel.  Products were visualized by 
autoradiography.  For sequencing primer extensions, four mixes were made in 
which the dNTP concentrations were halved, and the appropriate dNTP 
supplemented with 1/5 concentration of the corresponding ddNTP.  For primer 
extensions to assay relative levels of wild-type and orthogonal U2 snRNA, dTTP 
was replaced by an identical concentration of ddTTP in the reaction mix. 
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YEAST COPPER GROWTH ASSAYS 
Aliquots of saturated 1 ml RNA prep pre-cultures were diluted 1:5 with water, and 
8 µl spotted onto SD-Leucine plates containing various concentrations of CuSO4.  
Typical copper concentrations used were (in µM): 0, 25, 50, 75, 100, 200, 300, 
400, 500, 600, 800, 1000, 2000. 
QUANTITATION OF SPLICING EFFICIENCY 
Primer extension results were visualized by autoradiography: films were 
photographed the resulting image files converted to grayscale.  Lanes were 
defined and the area under peaks corresponding to bands of interest calculated 
using ImageJ.  Numbers thus obtained were used in Excel to calculate splicing 
efficiencies. Where pre-mRNA, mRNA and lariat intermediate are P, M and LI, 
first step, second step, and overall splicing efficiency were defined as 
(M+LI)/(P+M+LI), M/(M+LI) and M/(P+M+LI), respectively.  
RT-PCR  
For RT-PCR reactions to amplify trans-spliced U2-ACT1-CUP1, yeast total RNA 
was treated with DNaseI (Sigma) according to the manufacturer’s instructions.  
Reverse transcription was carried out (using the primer extension protocol 
described above) on the equivalent of 2 µl total RNA, using the primer YAC94 5’-
CGTCGCTGTTACACCC-3’.  Reverse-transcribed DNA was amplified for 22 
cycles using primers YAC94 and yU2-22 5’-ACGAATCTCTTTGCCTTTTGGC 
(53.5 ˚C annealing temperature), diluted 1:1000 and further amplified using 
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primers yU2-22 and YAC6 5'-GGCACTCATGACCTTC-3' (30 cycles).  Products 
were separated in 2% agarose gels.  RT-PCRs for loading controls were 
performed with yU2-138-154 5’-AAAGTCTCTTCCCGTCC-3’ and yU2-22 as 
antisense and sense primers, respectively.  PCR products were purified for 
sequencing and cloning using Qiaquick gel extraction kits (Qiagen) according to 
the manufacturer’s instructions.  RT-PCR reactions to amplify spliced ACT1-
CUP1 and ACT1-U2-ACT1-CUP1 products used YAC94 and YAC11 5’-
(**SEQ??), and did not require re-amplification with nested primers. 
YEAST WHOLE CELL EXTRACT PREPARATION 
2 l cultures were grown to O.D. ~3 in YPD (or O.D. 1.5 in SD-His if a second-
copy U2 snRNA was to be maintained) and collected by centrifugation at 3500 
rpm for 5 minutes.  Cells were washed once with 200 ml cold H2O and with 50 ml 
then 20 ml of cold buffer AGK (10 mM HEPES, pH 7.9, 1.5 mM MgCl2, 200 mM 
KCl, 10% glycerol, 0.5 mM DTT): if resuspension was difficult, a sterile 25 ml 
Pasteur pipette was used.  A slurry was then made by adding an amount of cold 
AGK corresponding to around 0.4x the volume of the cell pellet.  To this was 
added 2 µl 1x EDTA-free protease inhibitor cocktail V (Calbiochem).  The slurry 
was dripped into liquid nitrogen using a p1000, expelling around 200 µl per drop, 
and stored at -80 ˚C before further processing.  The frozen cells were ground 
using a Retsch MM301 ball mill exactly as described in the technical literature 
(available at http://www.retsch.com/products/milling/ball-mills/mm-400/product-
information/dlDetails/1/file/1538/), using 5 cycles of 3 min at 10 Hz.  The powder 
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was thawed at room temperature, stirred gently at 4 ˚C for 20 min, then spun at 
35,000g for 30 min (for large volumes, a J-20 rotor was used; for small volumes, 
a TLA 100-3 rotor was used at 25,000 rpm).  The aqueous phase between the 
top lipoprotein layer and the pellet was carefully collected, and spun again at 
100,000g  for 1 hr (43,000 rpm, TLA 100-3 rotor).  Again, the aqueous phase was 
collected.  This was dialysed in MwCO 10,000 tubing against 5 x 200 ml buffer D 
(20 mM HEPES, pH 7.9, 0.2 mM EDTA, 50 mM KCl, 20% glycerol, 0.5 mM DTT), 
changing the dialysis buffer every 30 min.  The dialysed preparation was kept on 
ice and dropped 20 µl at a time into liquid nitrogen before storage at -80 ˚C. 
IN VITRO SPLICING 
4 µl yeast whole cell extract was added to tubes containing 1 µl 20 mM ATP, 
1fmol splicing substrate (in 1 µl), 1 µl 60 mM KHPO4, pH 7.0, 1 µl 25 mM MgCl2, 
1 µl 30% PEG-8000 and 1 µl of either H2O or superasein (Ambion).  Placental 
RNase inhibitor must not be used, as it does not work in the absence of DTT and 
in fact acts as a source of co-purified nucleases.  Reactions were carried out at 
room temperature. After the appropriate amount of time, these were stopped via 
the addition of 240 µl H2O and 200 µl 50:50 phenol:chloroform.  Reactions were 
extracted before ethanol precipitation in the presence of 10 µg glycogen (one 
extraction was required for clean results with UBC4 substrates and two with actin 
substrates).  Freezing the tubes in dry ice immediately after the initial addition of 
water and phenol:chloroform helped to produce pellets that could readily be 
150 
resuspended.  Pellets were resuspended in formamide + dyes, then loaded on 
denaturing polyacrylamide gels. 
SEPARATION OF SPLICING COMPLEXES IN NATIVE ACRYLAMIDE 
AGAROSE GELS 
3 µl aliquots of splicing reactions were taken after an appropriate incubation, and 
added to ice-cold tubes containing 3 µl 50% glycerol with xylene cyanole and 
bromophenol blue, and 3 µl Buffer R (2 mM MgOAc, 50 mM HEPES-NaOH, pH 
7.5) containing either HeLa or S. cerevisiae total RNA.  This mixture was kept on 
ice for 10 minutes then loaded directly onto 3.5% acrylamide/agarose gels (3% 
acrylamide, 80:1 aa:bis, 0.5% agarose; 50 mM Tris, 50 mM glycine). Gels were 
prepared with a 10% acrylamide plug at the bottom to prevent the gel from sliding 
out from between the glass plates, and were run until xylene cyanole was 
approximately 2/3 of the way through the gel.  Gels were run at room 
temperature at currents low enough to avoid heating, which would dissociate 
splicing complexes.  After running, gels were dried and exposed directly to film. 
DETERMINATION OF RELATIVE GROWTH RATES OF S. CEREVISIAE 
STRAINS 
Growth rate data were collected using a Bioscreen C™ analyzer: cells were 
grown in minimal medium lacking histidine in order to ensure retention of U2 
snRNA-encoding plasmids, and containing 0.1% NP-40 to prevent cell clumping.  
Relative growth rates were calculated from the relative gradients of the linear 
regions of graphs of ln(O.D.) vs time.  Data were collected from three 
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independent cultures of each strain, allowing mean growth rate and standard 
deviations to be calculated. 
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